what incivo is incivo works by inhibiting the activity of the virus that causes hepatitis c infection . it is used in adults , adolescents and children aged 18 years and older who are already taking peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . what incivo looks like and contents of the pack incivo belongs to a class of medicines called cytokines . cytokines are proteins produced in the body that help your body make better use of its own immune system ( the body ' s natural defences ). this is a type of hepatitis c virus
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo if : - you are taking peginterferon alfa or ribavirin . - your doctor may need to adjust your dose of incivo or to adjust the dose of their contraindications ( e . g . pregnancy precautions ). - you have been prescribed incivo by your doctor to lower the amount of the active substance in your body . - you do not need to take pe
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose regimen is one tablet once a day . you should take the tablet at the same time each day . if you take more incivo than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . your doctor will tell you how many tablets of incivo to take and how often to take them . you may need to take both hepatitis c virus infection and human immunodeficiency virus infection ( efaviren
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop taking incivo and contact your doctor immediately . if the rash gets worse , tell your doctor straight away . other symptoms of the rash may include : - a severe skin reaction . - a skin rash . - if you notice any of the following symptoms of your rash : - swelling of lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin blisters , blisters in the mouth , eyes , and / or genitals . if your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicinal product does not require any special storage conditions . incivo tablets should be kept in the bottle in order to protect from light . the bottle should be used immediately .
what incivo contains - the active substance is telaprevir . each tablet core hypromellose acetate succinate . - the other ingredients are calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidalanhydrous , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack film - coated , yellow caplet - shaped tablets are
the active substance of zinbryta is daclizumab beta , which is a monoclonal antibody . it is a type of protein that attaches to receptors in the brain and spinal cord . it attaches to these receptors and blocks the action of the protein . how and when to use the active substance in the treatment of multiple sclerosis : therapy is usually two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( the brain or spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms ( repeated attacks (
do not take zinbryta : - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . possible signs of liver problems ). warnings and precautions talk to your doctor , pharmacist or nurse before you or your family or carer is given this medicine . check with your doctor or pharmacist if you are not sure . your doctor may need to adjust your dose or change your dose if : - you have ever had liver problems . this medicine is not recommended in patients with any other autoimmune disorders . - you are taking any other
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . the recommended starting dose is 40 mg twice a day , depending on the results of this blood test . if your doctor thinks you may need more treatment than you should , your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) changes in the colour of your skin or your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may affect up to 1 in 100 people : severe inflammation of the liver which may lead to death
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the zinbryta pre - filled syringe and the carton after exp . store in the original package in order to protect from light . a new syringe / pen should be kept in a refrigerator at room temperature ( up to 30 ) for a single period of no longer than 30 days . once a syringe has been removed from the refrigerator and is ready to be used , it must be used within 30 days or disposed of . if you have any further questions on
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( 23 milligrams ) of dacluzumabbeta . 1 ml of solution for injection contains 150 mg ( 23 . 5 milligram ) of the other ingredients ( listed in section 6 ). - the other ingredient ( s ) are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 for further information on the use and handling of this product ). what zinbaryta looks like and contents of the pack z
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this result can lead to liver damage and neurological disorders . wilzin works by slowing down the accumulation of copper in the intestine and its further accumulation in the body . if you have any further questions on the use of this treatment , ask your doctor or pharmacist .
do not take wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking wilzin wilzin is for initial therapy only . signs and symptoms of wilson ' s disease are currently being treated with another anti - copper agent called penicillamine . if you take more wilzin than you should if you accidentally take too many tablets , contact your doctor or pharmacist immediately . the initial treatment with other anti - copper agents may need to be slowed down or stopped . pen
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the recommended starting dose is 25 mg / 50 mg twice a day . the recommended dose is 1 mg wilzin ( 50 mg / 2 mg ). your doctor will tell you how many tablets of wilzin to take at the same time each day . if you take more wilzin than you should if you forget to take a dose , take it as soon as you remember . however , if it is almost time for your next dose , skip the missed dose and
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported with wilzin : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) frequency not known ( frequency cannot be estimated from the available data ): very common : may affect up to 1 in 10 users 1 , 000 units per kilogram body surface area less than 1 square metre ( 0 . 5 % of the body surface surface area ) not known : frequency not estimated from available data is not known . if you have any further questions on the use of this medicine
keep out of the sight and reach of children . do not use wilzin after the expiry date which is stated on the carton and on the label after exp . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each 25 mg hard capsule contains zinc equivalent to 83 . 92 micrograms of zinc ( equivalent to zinc acetate dihydrate ) in 50 mg hard capsules . the other ingredients are : capsule content : capsule contents : capsule shell : shellac , gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg capsules are white to off - white , capsule shaped , imprinted with ' wilzin 50 mg '. the printing ink is printed with black iron oxide ( e172 ) and shell
biktarvy contains the active substance bictegravir , which is an antiretroviral medicine known as an integrase strand transfer inhibitor ( emtricitabine ). it is also a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide . it is not an antiviral medicine but it is a nucleotide reverse transcriptionase inhibitors ( trti ). biktarv is used for the treatment of human immunodeficiency virus ( hiv ) in adults , adolescents and children aged 1 year and above . hiv is a type
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : rifampicin ( used to treat some bacterial infections ) - tuberculosis - st . john ' s wort ( hypericum perforatum ) - a herbal remedy for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking biktorvy : if you have liver problems . liver disease is a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the other ingredients are : antacids to prevent stomach ulcers , heartburn and acid reflux , magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about these medicines "). biktarvy may be taken with or without dialysis . if you take more of these medicines than you should if you accidentally take too many of them , talk to a doctor or go to the nearest hospital emergency department immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following signs of inflammation or infection : advanced hiv infection may be caused by opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation may be similar to those of previous infections . before hiv treatment is started , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against hiv . these symptoms are due to a weakness immune system , which can cause symptoms such as inflammation or previous infections to become active again . during hiv
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg / m2 film - coated tablet ( tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate ). - the other ingredients are film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc , iron oxide red ( e172 ) and iron oxide black ( e 172 ). what bibtarvy looks like and contents of
novonorm is an oral antidiabetic medicine that contains repaglinide . it works by helping your pancreas make better insulin to control your blood sugar ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin when the sugar in your blood is too high or too low . the insulin that your body makes does not work as well as it should . novonorm helps your body to make better use of the insulin it produces . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . diet and exercise and weight reduction can help control your
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high . warnings and precautions diabetic ketoacidosis ( a severe liver disease ) has been reported in patients treated with gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you suffer from liver problems . no vonorm should not be used in patients with moderate liver disease . if any of these apply to you , tell your doctor before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take it at least 30 minutes before or at least 4 hours after food . your doctor may increase your dose to a maximum of 30 mg once daily for up to 16 weeks . this will help control your blood sugar . if you have a hypo , talk to your doctor , pharmacist or nurse before you start taking novon
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of novonorm ( may affect up to 1 in 10 people ). if you have a hypo in section 2 of this leaflet , talk to your doctor or pharmacist straight away if you experience any of the following symptoms : swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects may include : very common ( affects more than 1 user in 10 ): stomach pain diarrhoea uncommon ( affects 1 to 1 users in 1
what novonorm contains the active substance is repaglinide . the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer . tablet coating : iron oxide yellow ( e172 ), 1 mg , iron oxide red ( e 172 ) ( see section 2 under " no vonorm contains lactose "). what it looks like and contents of the pack nvonorm tablets are white to off - white
pumarix is a vaccine for use in adults , adolescents and children aged 18 years and older . pandemic flu ( influenza ) is a type of influenza that occurs every few decades . it is very common ( may affect more than 1 in 10 people ) in the world , but it can also occur in many countries , including those in the european region , where it is not known ( frequency cannot be estimated from the available data ). when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection against the disease . none of the ingredients in the vaccine can
do not use pumarix if you have had a sudden life - threatening allergic reaction to any of the ingredients of this vaccine ( listed in section 6 ). the ingredients are : chicken protein , ovalbumin , formaldehyde , sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath , swelling of the face or tongue . if any of these apply to you , stop using the vaccine and contact your doctor immediately . medical treatment may be needed . if you develop signs of any allergic reaction , please tell your doctor , pharmacist or nurse immediately . if this happens , you should
pumarix is for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those of the other ingredients in this vaccine ( listed in section 6 ). the recommended dose is one injection into a muscle in the upper arm . if you have any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure ( shock ) and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain at the site of the injection headache tired aching muscles joint pain common ( might affect up to 1 in 100 people ) redness or swelling at the injection fever sweating shivering diarrhoea feeling sick uncommon ( likely to affect 1 to 100 people ): the injection may cause bruising or a hard lump itching warmth swollen glands in your neck
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the suspension in order to protect from light . once the vaccine has been mixed with the suspension , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 30 .
what pumarix contains - the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ). each vial contains 0 . 5 mg haemagglutinin , which is used to prevent the pandemic . - the vaccine contains an ' adjuvant ' as03 . this adjuvanted contains salqualene , dl - α - tocopherol , polysorbate 80 and adjuvants . the other ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what pumar
somakittoc is a radiopharmaceutical product that contains the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the other ingredient in this product ( excipients ) are gallium , 68ga , and indigestion . this procedure allows the amount of gallium in the blood to be reduced . the dose that is given depends on the type of medicine you are taking . it is given by injection into a vein or into one of your body areas . this is a medical imaging procedure called positron emission tomography ( positromission tomography
do not take somakittoc : - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you experience an allergic reaction ( see section 4 ). if you have kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents ( from 18 years of age ) the risk of allergic reaction is not known ( cannot be estimated from the available data ). the examination should be repeated every 28 days . there are others medical conditions that affect the functioning of the
there are strict laws on the use of radiopharmaceutical products . somakittoc should not be used in children and adolescents below the age of 29 years . the nuclear medicine doctor supervising the procedure will decide the correct dose of somakitontoc . the recommended dose of the product is 100 mg / m2 . the dose may be increased up to 200 mg megabecquerel per kg of body weight . the maximum recommended dose to be administered by your nuclear medicine physician is one dose . if you have any questions about the procedure or about the effects of radiolabelling , please ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ). somakittoc may cause symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : storage of somakittoc in a refrigerator ( 2 - 8 ). keep the vial in the outer carton in order to protect from light . storage at room temperature ( up to 25 ) does not result in deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg edotereotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solvent for the solution is hydrochloric acid . - radiopharmaceutical preparation is provided in a glass vial with black flip - off cap . - a white powder is supplied as a clear and colourless solution . the radioactive substance is
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus slows down or stops the growth of cancer cells . afinitor works by blocking a hormone receptor ( hormone receptor ) that is involved in the development of positive advanced breast cancer ( postmenopausal ). it belongs to a group of non - steroidal aromatase inhibitors that are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours ) in the stomach , bowels
always take afinitor exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of cancer treatment is one tablet once a day . do not take more than one tablet at the same time each day . talk to your doctor if you think you may be allergic to everolimus , sirolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told by your doctor that you are allergic to any of these ingredients , tell your doctor straight away . if you do not have any problems with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have liver problems , your doctor may prescribe a lower dose of finitor ( 5 mg ) or one 5 mg tablet ( 7 . 5 mg ). if you experience certain side effects , talk to your doctor , pharmacist or nurse before stopping treatment . how much to take take your tablet at the same time each day . do not take a double dose to make up for a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience an allergic reaction such as : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of the following side effects while you are taking the medicine : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ), fever , coughing , difficulty breathing , wheezing . inflammation of the lung ( pneumonitis 46 ). uncommon ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tablet in the outer carton in order to protect from light . after first opening the blister , remove the tablets from the refrigerator and allow them to reach room temperature ( up to 25 ). once the tablets have been removed from the fridge , they should be used within 30 minutes or disposed of in accordance with local requirements . do
what afinitor contains - the active substance is everolimus . each tablet contains either 2 . 5 mg / ml of solution . - the other ingredient is butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone and lactose anhydrous ( see end of this leaflet for further information on the other ingredients ). what afinfitor looks like and contents of the pack afinnitor is a white to slightly yellowish , oval - shaped tablet , debossed with " 5 " on one side and " l " on the
what laventair ellipta is and what it contains the active substance is umeclidinium bromide ( also called vilanterol ). this belongs to a group of medicines called bronchodilators . what it is used for and how it works it is important to tell your doctor or pharmacist if you have or have ever had chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . in copd the muscles around the airways tighten , making it harder for air to get in and out of the lungs . this medicine works by tightening these
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if you have asthma , tell your doctor straight away if you : - have asthma - have heart problems - have high blood pressure - have an eye problem called narrow - angle glaucoma ( an enlarged prostate ) - have difficulty passing urine - have a blockage in your bladder - have epilepsy - have thyroid gland problems ( diabetes )
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one inhalation every 24 hours . always use laventair ellipta exactly as described in this leaflet . do not change the dose unless your doctor tells you to . if you do not feel better after the first 24 hours , use your quick - acting reliever inhaler ( such as salbutamol ). if you have any further questions on the use of the inhaler , ask your doctor , pharmacist or nurse . what to do if you use more lav
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions tell your doctor immediately if you experience any of the following symptoms while taking laventair ellipta : very common side effects ( may affect more than 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect up to 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak , light headed , collapse or loss of consciousness . immediate breathing difficulties : if you have immediate breathing problems while taking
what laventair ellipta contains the active substances are umeclidinium bromide and vilanterol . each inhalation contains 55 micrograms ( 23 milligrams ) of the active substance in the body . each single inhalation delivers 65 mbq ( 23 . 5 milligram ) in each dose . the other ingredients in the inhalation powder are : tablet core : lactose monohydrate ( see end of section 2 for further information on lactose ') tablet coating : magnesium stearate ( e460 ) what laventAir ellipta looks like and contents of the pack lav
the active substance of tremfya is guselkumab , which is a monoclonal antibody . this medicine belongs to a group of medicines called il - 23 and is used to treat psoriasis in adults . it is used in adults to treat moderate to severe " plaque psORiasis " which is an inflammatory condition that affects the skin and nails . it works by reducing symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using tremfia if : you have an active infection ( active tuberculosis warnings , precautions , precautions and precautions ) you have ever had an infection or an infection with tuberculosis 36 you have a infection or symptoms of an infection that could be signs of infections . if you develop allergic reactions , your doctor may recommend a vaccination during treatment with tremf
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). this may take up to 4 weeks or up to 8 weeks . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : serious allergic reaction , including difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help provide more information on the safety of this medicine . reporting of side effects if you get any side effects talk to your doctor or pharmacist . some
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the pre - filled syringe in the outer carton after exp . this medicine does not require any special storage conditions . if you notice that the solution is cloudy or contains large particles , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose 80 and water for injections . what tremfa looks like and contents of the pack solution for injection in a vial is a clear to slightly opalescent , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 or 1 single -
the active substance of trepulmix , treprostinil , is a substance that belongs to a group of medicines called prostacyclins . it is a hormone produced naturally in the body that helps to lower blood pressure by relaxing blood vessels , and helping to prevent them from clotting together . inoperable chronic thromboembolic pulmonary hypertension ( cteph ) is persistent or recurrentcteph and requires surgical treatment and exercise capacity . symptoms of the disease can vary from person to person , but are generally the same as those of patients who have not been previously treated for chronic tachycardolic pulmonary
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease that causes blood vessels in the lungs to become swollen , leading to a higher pressure in the blood vessels between the heart and the lungs . if you suffer from severe liver disease . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor if you : have a heart problem or have had a heart attack ( myocardial infar
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion under the skin into a small tube ( cannula ) in the abdomen ( thigh ). your doctor will show you how to use it . you will be carefully trained by your doctor . the recommended dose is one capsule of your treprostinil per kilogram of body weight . the pump will be connected to the infusion line in order to prevent accidental overdose . the usual dose is 1 capsule of 2 . 5
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain due to the infusion site reaction . if this happens , it may lead to bruising at the infusionsite . headaches , nausea , diarrhoea jaw pain ( common ) ( uncommon ) ( frequency cannot be estimated from the available data ): dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs , fluid retention hot flush pain in arms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . trepulmix vial may be kept at room temperature ( up to 30 ) for continuous subcutaneous infusion in a single reservoir ( syringe ) of undiluted turbulmix for up to 72 hours . this medicine does not require any special temperature storage conditions . damage or discolouration may occur if there are other signs of deterioration .
what trepulmix contains - the active substances are treprostinil and sodium salt . each ml of solution for injection contains one of the following active substances : trepiulmix 1 mg : the other ingredients are : 1 mg / ml ( sodium salt ) 10 mg : each vial contains one or more of the two active substances , respectively , in 10 mg ( 2 . 5 %) of the solution , and in 20 mg ( 10 % ) of the other ingredient , in 50 mg ( 6 %) or in 100 mg ( 8 %) treprosteinil ( as sodium salt ). trep
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ) produced by recombinant dna technology in the body . the recommended dose is 1 milligram per kilogram of body weight to prevent existing blood clots from forming ( see section 2 ). the other ingredient is 2 milligrams per milliliter of bodyweight to prevent the formation of clots in your blood . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). if you have an allergic reaction such as rash , swallowing , breathing problems or swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor straight away . a reaction with this medicine may be a severe drop in the number of your clotting cells ( platelets ). this
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . the bleeding should be stopped immediately . if you experience any bleeding event that appears as excessive bleeding , exceptional weakness , tiredness , paleness , dizziness , headache , or unexplained swelling , stop taking your medicine and contact your doctor immediately . talk to your doctor or pharmacist if you have any of the following : - a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel ( a blood clot ) - cramping pain , redness , warmth or swelling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after dilution the solution should be used within 8 hours . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the thorinane pre - filled syringes should be disposed of in accordance with local requirements .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 milligrams ( mbq ) of this active substance . the other ingredients are : powder for solution for injection ( see section 2 ), solvent for solvent for injections ( 0 . 2 ml ). colourless type i neutral glass syringe barrel with fixed needle and needle shield , chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 or 10 ready - to - use syringes . not all pack sizes may be marketed .
senstend contains the active substances lidocaine and prilocaine . both belong to a group of local anaesthetics . senstend is used to prevent lifelong premature ejaculation in the head of your penis after ejaculation .
do not use senstend : if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( such as amide - type local anesthetics ) if you suffer from a genetic disease or other condition that affects your red blood cells such as glucose or phosphate deficiency ( e . g . anaemia or methaemoglobinaemia ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if your face is affected by accidental contact with
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 mg once a day . the recommended starting dose is 1 mg twice a day for the head of your penis . this will be repeated every 3 to 24 hours for up to 4 weeks . keep the spray container in the outer carton in order to protect from light . do not use the pump nozzle if you notice that the pump mechanism is not working properly . contact with eyes , nose , mouth and ears is not
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : very common ( may affect more than 1 in 10 people ): inability to develop or maintain an erection in the penis feeling of burning in the area between the penis and the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling of the penis pain or discomfort around the penis itching of the area where the penis is inserted a high temperature reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 12 hours at room temperature . once the metal container has been reconstituted , it must be used
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms lidocaine ( equivalent to 50 microlitres ). - the other ingredients are : one 50 microgram ( 0 . 5 ml ) syringe : each syringe contains 7 . 5 microgram lidsocaine , equivalent to 2 . 5 milligrams lidsucaine . - each spray container contains 6 . 5 to 20 ml of solvent . each spraycontainer contains 5 to 12 ml of light yellow cutaneous spray . - the solvent is an aluminium spray container with met
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ). in adults melanoma is usually treated with complete resection in adults ( treatment with surgery or adjuvant therapy ). in advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with previous therapies , including an autologous stem - cell transplant ( a transplant ) advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) nivolumab is a monoclonal antibody
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have problems with your heart , such as a change in the rhythm of the heartbeat , an abnormal heart rhythm , breathing difficulties , cough , inflammation of the lungs ( pneumonitis ) or interstitial lung disease ( diarrhoea , watery , loose or soft stools ). if you experience any symptoms of inflammation of any intestines ( colitis ), such as
always take opdivo exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 240 mg tablet once a day ( 2 tablets of 480 mg ) for the first 4 weeks of treatment . your doctor may increase the dose of ipilimumab depending on how you respond to the treatment . if you have skin cancer , your doctor will prescribe you a lower dose ( 1 tablet of nivolumab per kilogram of your body weight ) which will be given at least 4 weeks after your last dose . if your doctor thinks
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg , 10 mg , 240 mg or 24 ml of solution . - the other ingredients are : tablet core : sodium citrate dihydrate , sodium chloride ( see section 2 for further information on sodium ). - solvent : mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opdiv
clopidogrel tad is a member of a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as thrombosis ). by blocking the action of these clots , antiplatelets prevent the formation of atherothrombotic events ( e . g . stroke , heart attack , or death ). if you have any of the following , talk to your doctor or pharmacist before taking clop
do not take clopidogrel tad : if you are more than 30 years of age . if you think that you may be allergic , ask your doctor or pharmacist for advice before taking this medicine . warnings and precautions talk to your doctor if you have a medical condition that is currently causing bleeding such as a stomach ulcer , bleeding within the brain or severe liver disease . if any of these apply to you , tell your doctor straight away . if your doctor thinks that you are not being treated for your condition , or if you currently have bleeding that is not being controlled , as your doctor may need to adjust your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of clopidogrel to be taken orally once a day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg ) than usual . if this happens , you should contact your doctor immediately . if it does not happen , talk to your doctor , pharmacist or nurse before you take clop
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what clopidogrel tad contains - the active substance is clopidoogrel . each film - coated tablet contains 75 mg of clopiodogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ] and talc and microgol 3000 ( e1520 ). what clop
tacforius contains the active substance tacrolimus , which is an immunosuppressant . tacforius works by preventing your organ transplant from coming back to your liver or kidney . this reduces the need for your body ' s immune system to reject the transplanted organ , thus increasing the risk of rejection by the liver , kidney , heart and any previous treatment that was not followed by your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide , antibiotic ( e . g . erythromycin , clarithromycin or josamycin ), or to any of these other ingredients ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given tacfius immediate release capsules . if you ( or your child ) have a prolonged - release , you should not be given tacro
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one tablet a day . transplant patients should take the same tacrolimus medicine at the same time each day . if you have had a transplant , your doctor may give you a different tacrolamus medicine . if this medicine does not work well enough for you , talk to your doctor , pharmacist or nurse before taking this medicine . always take the right medicine to prevent the rejection of your transplanted organ . the dose of tacforius depends on your body
like all medicines , this medicine can cause side effects , although not everybody gets them . infections stop taking tacforius and tell your doctor straight away if you notice any of the following serious or severe effects : allergic and anaphylactic reactions , which may be benign or malignant tumours , which have been reported in patients treated at the same time or at different times in patients who have been treated at a different time or have had them before : pure red cell aplasia ( a very severe reduction in the number of red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after opening the aluminium wrapping , tacforius should be used immediately .
what tacforius contains - the active substance is tacrolimus ( as monohydrate ). each capsule contains 0 . 5 mg / ml of solution for injection ( see section 2 ). - the other ingredients are capsule content hypromellose , 2910 , ethylcellulose , lactose , magnesium stearate ( e1520 ) and capsule shell tacforius is available in capsule shells containing 1 , 3 or 5 mg of solution ( for injection ) for injection , each containing 1 mg or 3 mg of preparation ( for injections ) for infusion , each contains 5 mg or 6 mg of titrolim
clopidogrel zentiva is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping and preventing them from clumping together they reduce the chances of blood clots forming ( a process known as thrombosis ). by blocking the ability of platelets to clump , it reduces the risk of developing clots ( thrombi ) forming in hardened blood vessels ( arteries ), which can lead to atherothrombotic events ( such as stroke , heart attack
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or pharmacist . you may need to take special precautions while you are being treated with the active substance . you should not be given clop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of clopidogrel zentiva per day . if you experience severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg / day ). if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic reaction . the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep clopidogrel zentiva in aluminium blisters in order to protect from light . once opened , the product should be used within 30 . keep the vial in the outer carton in order for it to reach room temperature ( not above 30 ). keep the bottle tightly closed to protect it from light and moisture . if not used immediately , in - use storage times
what clopidogrel zentiva contains the active substance is clopidoogrel . each tablet contains 75 mg of clopiodogrel ( as hydrogen sulphate ). see section 2 for further information on the contents of this leaflet . the other ingredients are : tablet core : lactose ' ( see section 4 for more information on this ). tablet coating : microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacetin , red iron oxide ( e172 ),
yttriga is a radioactive medicine that must not be mixed with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . the following information is intended for the general information only : - the active substance is a radioactive medicine . - the other medicinal product is radiopharmaceuticals . your doctor will decide on the appropriate dose for you . the use of ytt
yttriga will be administered under the supervision of a doctor experienced in the treatment of radiolabelling of medicinal products for specific diseases . your doctor will supervise the treatment and will determine the appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga must not be disposed of via wastewater or household waste . local regulations on radioactive substances and waste material should be followed .
what yttriga contains - the active substance is chloride . each ml contains 1 ml sterile solution . - the other ingredients are hydrochloric acid and water for injections . each vial contains 3 ml of solution with a v - opened bottom and a colourless type i glass vial containing 10 ml with a flat bottom with a silicon stopper and an aluminium seal .
ciambra is a medicine used to treat cancer . ciambra contains the active substance cisplatin , which is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma ( a type of cancer that affects the lining of the lung ) in adults who have not received prior chemotherapy . in patients with this type of lung cancer , the initial treatment is given to you by a doctor or nurse . if you have lung cancer that has spread to other parts of your body , your doctor may decide to give your medicine another course of treatment . initial chemotherapy is usually given in combination with
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before breast - feeding . before starting treatment , you should tell your doctor if : - you have a vaccine against yellow fever . - you are not sure what to do if any of these apply to you . if you have problems with your kidneys . your doctor will check your blood before and during treatment to make sure that you have enough of cisplatin to receive appropriate treatment . cispl
always use ciambra exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 500 micrograms per kilogram of your body ' s surface area . this means that your height and weight are evenly distributed across the body . your doctor will work out the right dose for you based on this body surface area and will adjust your dose depending on your response to treatment and on your blood cell counts . the infusion will take approximately 9 minutes . the other ingredients are sodium chloride solution and water for injections ( see section 2 ). the dose you receive will depend on your
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor straight away if you experience fever or signs of infection ( such as a temperature or sweating ). infection may affect more white blood cells than normal . infection may lead to sepsis ( death ). chest pain with a fast heart rate , pain , redness , swelling or sores in your mouth . signs of allergic reaction include skin rash , burning or prickling sensation and fever . skin reactions can lead to death . a severe rash , itching or blistering ( stevens - johnson syndrome or toxic epidermal ne
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the infusion solution of pemetrexed . this medicine will be stored in a refrigerator ( 2 - 8 ) for up to 15 days at room temperature ( not above 25 ). the reconstituted solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , 15 to 25 . any unused solution must be discarded .
what ciambra contains - the active substance is pemetrexed . each vial contains 100 mg / ml of solution for infusion . - the other ingredients ( excipients ) in the vial are : one 100 mg vial : one 500 mg film - coated syringe : one vial of powder for concentrate for solvent for solution for injection . - each 500 mg ( 2 500 mg ) vial ( 3 500 mg ), one 500 ml ( 3 600 mg ) or one 600 mg ( 3 800 mg ) powder for infusion : one white lyophilised powder , one glass vial with rubber stopper
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that help prevent certain infections from getting into your blood . immunogam is used to prevent increased levels of human hepatitis b immunoglubulins , which are produced in the body by biotechnology in the laboratory , by blocking the action of immunoglofulin g ( gg ) in blood plasma of screened patients . your doctor will test your body for these antibodies before and during treatment with immunogogam . the recommended dose is one tablet once a day , with or without food , at the same time each day . immun
always use immunogam exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have an allergic reaction to human immunoglobulins or other blood products ( i . e . an iga deficiency ) or to any of the other iga containing products listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given Immunogam . signs of adverse reactions include chills , headache , fever and vomiting . allergic reactions may include nausea ( arthralgia ), joint pain , low blood pressure and moderate low back pain
always use immunogam exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . vaccination with hepatitis b virus the first vaccine dose is human hepatitis b immunoglobulin . administration prevention the recommended dose of hepatitis b is 500 micrograms per kilogram of body surface area every 24 hours for 72 hours . if you have hepatitis b in haemodialysed patients , your doctor may prescribe a lower dose of 500 subcutaneous units ( iu ) every 2 weeks . seroconversion following vaccination insulination is recommended for individuals who are
like all medicines , immunogam can cause side effects , although not everybody gets them . the most commonly reported side effects are : very common ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 100 people : very commonly , may affect less than 1 out of 10 people : common : 1 in 1 , 000 people : not known ( frequency cannot be estimated from the available data ): very rare cases of very rare instances of undesirable effects have been reported in clinical trials . if you are not sure , talk to your doctor , pharmacist or nurse . the following side effects may occur with immun
keep out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label of the vial after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2ºc - 8ºc ). do not freeze . protect from light . from a microbiological point of view , the product should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
immunogam contains the active substance human hepatitis b immunoglobulin . immunogam 1 mg solution for injection in a glass vial contains 5 mg of human plasma protein . the other ingredients are : polysorbate 80 and water for injections ( see end of this leaflet for further information on the contents of this pack ). what Immunogam looks like and contents of the pack autogam is presented as a clear to slightly opalescent , colourless to pale yellow liquid . it is available in packs containing 1 vial .
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnf ). remicade belongs to a group of medicines called 'tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis and ankylosing spondylitis ( bechterew ' s disease ) and psoriasis in adults , adolescents and children aged 6 years and older . these include crohn ' s
do not take remicade : if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ). if you think you may be allergic ( hypersensitive ) to any of these ingredients . if you have tuberculosis ( tb ) or another serious infection , e . g . pneumonia , sepsis or heart failure . warnings and precautions talk to your doctor , pharmacist or nurse before you are taken or while you are being treated . you should not take the medicine if your doctor has told you that you are hypersensitive to the presence of tb in the past .
always take remicade exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : rheumatoid arthritis ( 3 mg / kg body weight ) psoriatic arthritis ( ankylosing spondylitis or bechterew ' s disease ) psoriasis ( ulcerative colitis ) crohn ' s diseases the recommended starting dose is 5 mg per kg of body weight . your doctor will tell you how many tablets to take . how much to take the usual dose is one tablet once a day . if you take more remic
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some serious side effects may occur during treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction ( swelling of your face , lips , mouth or throat ), difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions may be signs of an allergy reaction ( see section 2 " possible allergic side effects "). - pain in the muscles , fever , joint
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . remicade may be stored at room temperature ( up to 25 ) for a single period of up to three weeks . after reconstitution and infusion , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixamab in 10 ml solution . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate , and water for injections ( see end of section 2 for further information on the contents of the pack ) and sucrose . the ingredients in the powder for concentrate for solution for infusion are : white to off - white powder . the powder is clear to opalescent and colourless to pale yellow . pack sizes of 1 , 2 , 3 ,
rasagiline mylan is used to treat parkinson ' s disease in adults . it belongs to a group of medicines called levodopa . it is used in combination with another medicine used in the treatment of parkinson ', s disease , to reduce the amount of dopamine in the brain . dopamine is a substance produced in the body that helps your body to make better use of its muscles . movement control is a key part of the body ' s natural response to stimuli that are present in the form of dopamine . dopamine stimulates the brain to produce more dopamine , which is important in movement control and for the overall health of the
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression in patients with parkinson ' s disease . - medicinal or natural products such as st . john ' s wort , pethidine , a strong pain killer . see section 14 for further information on the safety of r
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan : very common side effects ( may affect more than 1 in 10 people ): very common abnormal movements ( dyskinesia ) headache common abdominal pain common 1 , 000 rare cases of fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite constipation dry mouth nausea vomiting flatulence abnormal results of blood ( leuc
what rasagiline mylan contains - the active substance is raspiline . - the other ingredients are : capsule content : capsule contents : raspigiline tartrate ( 1 mg / ml ). capsule shell : shellac , microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid ( see section 2 for further information on the use of this product in children and adolescents ). tablet coating : white to off - white , oval , biconvex tablets containing 1 tablet . the tablets are available in blister packs containing 7
do not take hulio : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection such as tuberculosis . symptoms of infections such as fever , wounds , feeling tired or dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . allergic reaction allergic reactions include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions can be life threatening . infections tell your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . for polyarticular juvenile idiopathic arthritis the recommended starting dose is 2 mg once a day . children and adolescents from 2 to 17 years of age weighing 10 kg or more : one 30 mg tablet of hulio in the morning and one 40 mg tablet in the evening . for enthesitis - related arthritis , the recommended dose is 6 mg twice a day , taken at the same time each day . if you weigh more than 15 kg , your doctor may increase your dose to 30 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ) - after the last hulio injection - allergic reaction - heart failure - severe rash , hives swollen face , hands or feet - trouble breathing or swallowing - pale complexion - dizziness - persistent fever , bruising or bleeding - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulaio looks like and contents of the pack haulio 40 mg / ml solution for injection is a sterile solution containing 40 micrograms ( 0 . 8 milligrams ) in each ml . the solution is clear and colourless to slightly opalescent . it is supplied in a clear glass vial with a rubber stopper . each pack of hul
what yellox is yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . how yellox works yellox reduces eye inflammation following cataract surgery .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma , skin allergy or intense inflammation in your nose . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . nsaids may include acetylsalicylic acid , ibuprofen , ketoprofen and diclofenac . this medicine may be used in combination with topical steroids ( such as cortisone ). unwanted side effects such as bleeding problems ( e . g . haemophilia in the past
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one drop in the eye ( s ) twice a day . the recommended daily dose is 2 drops in the morning and one in the evening . the drops should be used every day for the next day of your cataract surgery . method of administration yellox is for oral use . wash your hands thoroughly with soap and water before using the eye drops . remove the bottle cap from the bottle . hold the bottle tightly closed with your thumb
what yellox contains - the active substance is bromfenac . - the other ingredients of the solution ( excipients ) of yellox are sodium sesquihydrate ( equivalent to 33 mg / ml ). - the following ingredients are present in the tablet core : boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide ( for acidity levels ). what yellox looks like and contents of the pack yellox is a clear yellow liquid (
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids and is used to treat sudden moderate - to - severe pain .
do not take dzuveo : if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo . if you suffer from any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ). if any of these apply to you , tell your doctor or pharmacist before you start treatment . you may have a head injury , brain tumour , problems with your heart and circulation ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be used immediately after you have taken this medicine . the recommended dose of dzuveo is one tablet of strong painkillers such as sufentanil 30 mg twice a day . the sublingual tablet should be swallowed whole with a glass of water . the disposable single -dose applicator can be taken with or without food . the applicator should be placed on the tongue . if the tablets dissolve in the tongue , there may be pain relief . the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , such as slow and shallow breathing . stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick or feeling hot . these may be the most commonly reported side effects . uncommon side effects may affect up to 1 in every 10 people : - inability or difficulty sleeping , feeling anxious , confused , dizziness , headache
keep this medicine out of the sight and reach of children . do not use dzuveo after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . after dilution , this medicine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours at room temperature ( up to
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of this medicine . - the other ingredients ( excipients ) are : tablet core : citrate , mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . tablet dimensions : 3 mm x 3 mm . - supplied as a single - dose applicator ( labelled [ sublingual tablet ]). - the applicator is a clear , colourless to slightly opalescent tablet . one su
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and has not responded to surgical treatments . this type of sensitive prostate cancer is usually eliminated from the body by surgical treatment . erleada increases the levels of testosterone in the blood and reduces the amount of resistant prostate cancer cells that can be killed by taking androgens . when the cancer has responded to androgens , the medicine stops the production of androgens that are needed to kill it . it works by blocking the release of the androgens from the prostate . ap
do not take erleada if : you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant or breast - feeding . if you think you may be pregnant or are planning to have a pregnancy , ask your doctor for advice before taking this medicine . contraception section warnings and precautions talk to your doctor , pharmacist or nurse before you take this medicine , as this medicine may increase the risk of seizures . you are taking any medicines to prevent blood clots ( such as warfarin or acenocoumarol ). you have any heart or blood vessel
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day for up to 60 days . if you take more erleada than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . this medicine can be taken by mouth or by injection . take the tablet with or without food . do not swallow the tablet whole with a glass of water . you may find it easier to swallow the tablets whole with some water . it is important to take erle
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are : fits ( seizure ) uncommon ( may affect up to 1
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 milligrams ( mbq ) of this active substance . - the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate . tablet coating : microcrystalline cellulose ( e460 ), silica ( e464 ), talc , and titanium dioxide ( e171 ). the film - coating : iron oxide black , iron oxide yellow , macrogol , polyvinyl alcohol , tal
arsumin is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is given to you by a doctor or nurse as a scan ( a pet scan ) in patients who have previously received treatment for prostate cancer . your doctor will do other tests to check the presence of prostate specific antigen ( psa ) in the cancer before you receive an axumin pet scan to check that the cancer has responded to the test . the scan will be repeated every three weeks . if you have any further questions on the use of axumin , ask your doctor , nurse or pharmacist .
do not use axumin : if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin . if you have kidney problems . you should follow a low sodium diet . axumin is given once a day for a day . the axumin scan will take about 4 hours . during the scan , you will be given your usual medicines for the latest 60 minutes . it is important that you drink plenty of water before and during the 60 minutes after your axumin injection to avoid urination .
always use radiopharmaceutical products exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of axumin is one tablet once a day . always use this medicine exactly as described in this leaflet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much axumin to use the usual dose is 370 micrograms megabecquerel per kilogram of body weight . how to use axumin for the procedure axumin will be injected into a vein by a flush of sodium chloride solution
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ) when the medicine was given in combination with axumin . very common side effects when axumin was given with 100 mg of the active substance are pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical emits ionising radiation which can cause cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg ( 1 , 000 iu ). - the other ingredients in axumin are : tablet core : white to off - white powder ; tablet coating : white , round , with a diameter of 1600 iu ; tablet coat : red , flat , and with a width of 32000 iu . - printing ink : sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see end of section 2 for further information on axumin ). what axumin looks like and contents of the pack
azopt contains the active substance brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to relieve high pressure in the eye , an illness known as glaucoma . by lowering the pressure in your eye , azopt prevents damage to your sight .
do not take azopt if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor , pharmacist or nurse before taking azopt . the same allergy may occur with too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you ( or you are not sure ), tell your doctor before taking
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the eye each day . your doctor will tell you how many eyes to use . if you use more azopt than you should if you accidentally use too many drops in one day , contact your doctor straight away . how to use the azopt bottle : wash your hands thoroughly with soap and water . remove the cap from the bottle and place it on the top of your head . snap collar on the bottle . hold the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ): blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . if any of the side effects gets serious , or if you notice bad taste , stop taking azopt and contact your doctor straightaway ( see also section " uncommon side effects " below ) - effects that may occur in more than 1 in 100 people : sensitivity to light , inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . to protect from infections azopt is available in a pack containing a single bottle .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of biconvex . - the other ingredients of azopt are benzalkonium chloride , carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap .
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines that are taken by mouth to treat diabetes . it works by helping control the level of sugar in your blood . it is used in adults , adolescents and children aged 18 years and above . the recommended dose is one tablet a day . if you have diabetes called type 1 diabetes , your body does not make enough insulin to control it . this is partly linked to the way your body makes too much sugar . in some people , the insulin that your body produces does not work as well as it should . diabetes can
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness . - a sweet smell to your breath , a sweet or metallic taste in your mouth , a different odour to your urine , sweat or rapid weight loss . if any of these apply to you , tell your doctor or pharmacist before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for adults with type 2 diabetes is between 10 mg and 5 mg once a day . if you have a liver problem , your doctor may prescribe a lower dose . your doctor will tell you how many tablets to take . how much to take if you take too many tablets for the treatment of type 1 diabetes , the usual starting dose is between 5 mg and 10 mg per day . do not take more tablets than your doctor tells you to . this medicine swallow the tablets whole
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : angioedema ( may affect up to 1 in 10 , 000 people ) this is a severe infection of the urinary tract that can be life - threatening . if you get anglioedema , you may experience swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( type 1 diabetes ). it is common in people with 1 to 10 diabetes , but in some people with type 2 diabetes . it is
what forxiga contains - the active substance is dapagliflozin . eachforxiga 5 mg / 0 . 7 ml film - coated tablet ( tablet ) contains the following ingredients : - tablet core : tablet core ( tablet core ): tablet core ; tablet coating ( tablet coat : tablet coating : tablet - type a , microcrystalline cellulose , lactose ( see section 2 ' for more information on lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow
mepact contains the active substance mifamurtide . it works by stopping the growth of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults aged between 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy has not been able to stop cancer cells growing back .
do not take mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called ciclosporin or other calcium - urin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ). you have problems with your heart or blood vessels . you have a risk of blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before you start treatment . some of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of mepact is 2 mg mifamurtide per kilogram of body weight every 12 hours for 24 hours . your doctor will tell you how many of your mepact treatments you should take . this will depend on your chemotherapy schedule and on how you respond to your chemotherapy . the usual starting dose is 36 mg once a day . you should continue treatment for as long as prescribed by your doctor . if you have any further questions on the use of me
like all medicines , mepact can cause side effects , although not everybody gets them . these include chills , fever and fatigue . some of these effects may be transient ( may affect up to 1 in 10 people ). if you are taking paracetamol , you should contact your doctor immediately if you experience continuing fever or chills after 8 weeks of treatment . if you have an infection , such as rash , any problems breathing or wheezing , or any stomach problems , tell your doctor straight away . very common side effects these may affect more than 1 in every 10 people : fever , shaking , shivering , weakness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial in outer carton after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml for 9 days . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 9 days at room temperature ( up to 6 ). do not
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of myelodysplastic acid . - the other ingredients are : 1 - palmitoyl - 2 - ol - sn - glycero - 3 - phosphocholine ( see end of section 2 for further information on the use of this product ). 2 - dileoyl- 2 - opalescent glocogrel ( type a ) ( 0 . 08 mg / ml ) ( e470b ) ( i . e ., white to off - white homogeneous cake for infusion
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alphaagonists . mirvaso is used on the skin ( face ) to reduce redness associated with rosacea , a type of redness of the face that can be caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . miraso acts by blocking the blood vessels that supply the excess blood flow and redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . the medicine should not be injected under the skin . certain medicines used to treat depression and parkinson ' s disease : monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as maprotiline or mianserin
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is given under the skin or on the face . this medicine is given to you by a doctor or nurse . the recommended dose is one tablet per day . your doctor will work out the right dose for you . the dose is based on the size of your body , body surfaces , your eyes , mouth , nose or vagina . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you have any further questions on the use
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling or sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment may cause symptoms ( see section 2 " warnings and precautions "). contact allergy : allergic reaction ( rash ) rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ) has been reported in patients taking mirvas
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after " exp ". this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . once opened , mirvaso should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at room temperature ( up to 30 ). do
what mirvaso contains - the active substance is brimonidine . each vial of gel contains 3 . 3 mg of bimonidine ( corresponding to 5 mg / ml ). - the other ingredients in the vial are : bromonidine tartrate , carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " miraso contains sodium "). - the excipients in the carton are : sodium ( e1520 ), methyl parahyd
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody . it works by interfering with the immune system ( the body ' s natural defence system ) to reduce the risk of infection and spread of cancer . by attaching itself to a protein called human vascular endothelial growth factor ( vegf ), it blocks the growth of lymph vessels in the body . by blocking the vgf protein , it allows blood vessels to expand and provide more oxygen to the surrounding tissues . by inhibiting the vf protein from working , mvasi slows down tumour growth and allows
do not use this medicine : if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you ( or your child ) are allergic or hypersensitive to chinese hamster ovary ( cho ) cell products . warnings and precautions talk to your doctor , pharmacist or nurse before using mvasi if you : - develop holes in the gut wall ( inflammation inside the abdomen ). - have diverticulitis ( stomach ulcers ), colitis or chemotherapy . warnings , precautions , and precautions before you are given or are given mvas
always use mvasi exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dose your doctor will work out the right dose for you based on your body weight and the type of cancer you have . the usual starting dose is between 5 mg , 7 . 5 mg or 10 mg per kg of body weight . the dose may be increased or decreased depending on the severity of your condition . your doctor may increase or decrease the dose depending on how you respond to treatment with this medicine . if you have any further questions on the use of this medicine , ask your doctor , pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with mvasi : very common side effects ( may affect more than 1 in 10 people ): - difficulty in breathing - chest pain - redness or flushing of the skin - a rash , chills , shivering - feeling sick ( nausea ) - being sick ( vomiting ) tell your doctor straight away if you notice any of the side effects listed below . severe side effects may affect up to 1 in every 10 people : - high blood pressure - numbness or tingling in hands or feet -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep mvasi in theouter carton in order to protect from light . infusion solutions should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless dilution has taken place
what mvasi contains - the active substance is bevacizumab . each ml of solution contains 25 mg / ml ( 1 . 4 mg / 16 . 5 mg ) solution for injection . each 4 ml vial contains 100 mg / kg ( 2 . 8 mg ) of bevaxumab , which should be used immediately . - the other ingredients are : powder for solution for infusion : tablet core : trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . see the end of this leaflet for further information on the use of this product . what mvas
tecartus is a gene therapy medicine that is used to treat mantle cell lymphoma in adults . it is used in combination with other medicines to treat refractory mantle cancer lymphoma , in which your own white blood cells ( autologous anti - cd19 - transfduced cd3+ cells ) are not enough to fight the cancer . mantle cell lipoma is a cancer that affects the immune system ( the body ' s natural defence system ) that causes the production of b - lymphocytes ( a type of white blood cell ). in adult patients , tecartus works by blocking the release of these cells from the
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine : - if you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy ). see section 3 for more information . - if any of these apply to you ( or you are not sure ), your doctor may ask you to have tests and checks of your lungs , heart , kidney , blood pressure ,
tecartus consists of your own white blood cells . your cells will be given to you by a catheter placed into your vein ( a procedure call leukapheresis ). the number of yourwhite blood cells in your blood will be calculated by your doctor . the amount of your blood in your vein will depend on how well you respond to tecartus treatment . the recommended dose is 3 to 6 micrograms per kilogram of body weight per day . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . your doctor will decide on the right dose for you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of your side effects . if any of the side effects occur , you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness ( confusion ), memory loss , disturbances of brain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . the solution for infusion bag contains liquid nitrogen equivalent to 150 micrograms per ml . this medicine is made from genetically modified human blood cells or human - derived material . the product is stable for 36 hours at room temperature ( up to 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3+ cells . each specific single infusion bag contains a dispersion of anti -cd19 car t cells equivalent to 68 x 2 cd3 + cells . - the other ingredients are : 106 micrograms of anti , sodium chloride , human albumin and water for injections ( see section 2 for further information on the safety of this product ). - infusion : the product is supplied as an infusion bag in a metal cassette . each single infusion bag contains 68 cells of cell dispersion . not all pack sizes may
januvia contains the active substance sitagliptin , which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - four inhibitors ). this medicine helps to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine increases the levels of insulin produced by your body . by increasing the amount of this medicine , your blood sugar can be lowered , helping to control the level of sugar in your blood . this is important because it is very important that you continue to follow your doctor ' s advice about diet and exercise . if you are not sure , talk to
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have been diagnosed with pancreatitis ( see section 4 ). you have blistering of the skin ( bullous pemphigoid ) if any of these apply to you ( or you are not sure ), tell your doctor as soon as possible . you have had a disease of the pancreatreas called pancreatitis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 100 mg per coated tablet , taken once a day by mouth . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg per tablet , depending on how you respond to this medicine . your doctor will tell you how many tablets of this medicine you need to take . this medicine may be taken with certain other medicines that lower blood sugar . if your doctor determines that the effect of januvia is too strong or too weak , talk to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you experience any of the following side effects : severe and persistent pain in the abdomen ( stomach area ), which may reach through to your back , nausea or vomiting . these may be signs of an inflamed pancreas ( pancreatitis ). this is a serious allergic reaction with frequency not known ( cannot be estimated from the available data ). rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat , which may cause difficulty
what januvia contains - the active substance is sitagliptin . one tablet of each film - coated tablet ( tablet ) contains the following excipients ( see end of section 2 ). - the other ingredients are : tablet core ( tablet core : sitaglptin phosphate monohydrate 25 mg / ml ) - tablet coating ( tablet coating : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e
xultophy is a type of insulin that works by helping your body make better use of the insulin it produces . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin . the insulin that your body makes does not work as well as it should . this can cause blood sugar to rise . insulin degludec is a long - acting basal insulin that helps your blood sugar levels to control the level of liraglutide ( a substance present in glp - 1 ) and insulin during meals . xultophy can be taken with or without oral medicines
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will tell you how long you should continue to take this medicine . warnings and precautions 39 you have type 1 diabetes mellitus ( also known as ' ketoacidosis '). this is a condition in which your blood sugar levels are not controlled enough by diet and exercise . talk to your doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . do not take more than one tablet a day unless your doctor tells you to . this is to make sure that you are blind or have poor eyesight . your doctor will check your blood sugar level regularly while you are using xultophy . the usual starting dose is 41 mg twice a day ( two tablets a day ). your doctor may increase your dose if necessary . if you have any further questions on the use of xult
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with xultophy : low blood sugar is very common ( may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( which can lead to brain damage ) can occur . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . if the effect of low blood sugars is too strong or too weak , contact your doctor straight away . your doctor may need to adjust your blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at room temperature ( up to 8 ). however , if used within 21 hours , the product should be used immediately .
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml of solution contains 100 units ( 0 . 5 ml ) of insulin degluudec ( 3 . 6 mg ) and 50 units ( 1 . 8 millilitres ) ( 2 . 0 milligrams ). - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 for further information on the sodium content of the solution . pack sizes : 1 , 3 or 5 x
giotrif is a medicine that contains the active substance afatinib . it works by blocking the activity of two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 and her2 [ erbb2 ]) and erbb3 . both of these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working properly and stops cancer cells from growing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). your doctor will tell you how long you should be treated with this medicine . your first treatment will
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). if you have low body weight ( less than 50 kg ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have kidney problems . tell your doctor straight away if you experience the following side effects : lung inflammation ( interstitial lung disease ). you have liver problems . your doctor may need to perform some liver tests before you take this medicine . you have a severe liver disease . eye problems . severe dry eyes . inflammation of the transparent layer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more giotrif than you should if you accidentally take too many tablets of this medicine , talk to a doctor or go to the nearest hospital straight away . if possible , take the tablet at the same time each day . this medicine can be taken with or without food . it is recommended that this medicine is taken at least 1 hour
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea very common ( may affect more than 1 in 10 people ): if you are not sure , talk to your doctor , pharmacist or nurse straight away ( see section 2 " possible side effects "). if you have severe diarrhoehoea , fluid loss ( common ) may occur ( rare ) but may be life - threatening . common : if you suffer from low blood potassium . worsening kidney function . if you experience any of the following symptoms after you have been given g
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 and water for injections ( see end of this leaflet for further information on the use of this product ). what giotratif looks like and contents of the pack
orkambi contains a medicine called ivacaftor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults , adolescents and children aged 6 years and older . it works by blocking a protein called f508del mutation , which is involved in the synthesis of cyst fibrosis transmembrane conductance regulator ( cftr ). the mcfr protein is found in the airways of the lungs . the mutation results in an abnormal cfr protein that does not work as well as it should . if you have problems with your breathing or with your lung function ,
do not take orkambi : - if you are allergic to lumacaftor , ivocaftor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . if you have been told by your doctor that the f508del mutation has been detected in your blood , your doctor may need to adjust your dose . if this applies to you , tell your doctor or pharmacist before you take this medicine . children and adolescents do not give this medicine to children under 6 years of age because the dose of or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg or 12 mg orkambi tablet once a day for 6 to 11 days . your doctor will tell you how many tablets to take each day . the recommended daily dose for adults , adolescents and children aged 6 years and above is one or two tablets a day . if you take more tablets than you should if you accidentally take too many tablets , or if someone else accidentally takes your tablets , talk to a doctor or go to the nearest hospital
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking orkambi with ivacaftor and talk to your doctor straight away if you notice any of the following serious side effects while you are taking it : very common ( may affect more than 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin and / or the whites of your eyes loss of appetite nausea or vomiting confusion dark urine other side effects which may affect up to 1 in 10 people : cough sputum nasal congestion
what orkambi contains - the active substance is lumacaftor . - the other ingredients are indigo carmine aluminium lake ( e132 ), povidone ( k30 ), sodium laurilsulfate , magnesium stearate . see section 2 for more information on the contents of the pack . - each tablet contains : - the content of the tablet is white to off - white , oval - shaped , biconvex , with " iv " debossed on one side and plain on the other side . - if you are not sure , talk to your doctor or pharmacist . -
the active substance of lynparza is olaparib , a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping mutations ( changes ) in a gene called brca ( breast cancer gene ) that can cause cancer to grow . parp inhibitors stop the growth and spread of cancer cells by blocking an enzyme needed to repair dna . what is dna ? dna is a substance present in many types of ovarian cancer . brca is a form of mutated ovarian cancer that arises after previous treatment with standard platinum -
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . children and adolescents do not give this medicine to children below the age of 6 years . the recommended dose is 2 mg / kg body surface area . if you have any further questions on the use of this product , ask your doctor or pharmacist . do not breast - feed . driving and using machines if you feel that your ability to drive or use machines is not being controlled with lynpar
always take lynparza capsules exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose for adults and adolescents is one 100 mg capsule twice a day . the dose may be increased to 150 mg once a day depending on how you respond to the tablets . if you take more tablets than you should if you forget to take a capsule , take it as soon as you remember and then take your next dose at the usual time . do not take a double dose to make up for a forgotten dose . if it is more than 8 hours since you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing , swallowing or dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening of the bottle , the bottle may be kept at room temperature ( up to 30 ) for a period of up to 3 days . if any capsules are not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of lauroyl macrogol - 32 glycerides . - the other ingredients are : hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ), and water for injections ( see section 2 under ' what you need to know before you take '). - the printing ink is a white , opaque , hard capsule imprinted with the company logo on one side of the capsule and plain on the other side . the capsule contains " olap
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the active substance nyxone is naloxone which is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine or morphine . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose . opioid overdose is a serious , life - threatening , and sometimes fatal , event that occurs within the first 14 days after an overdose . if you experience breathing problems , severe sleepiness or an opioid overdose , contact your doctor
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you have an opioid overdose . it is important that you tell your doctor or pharmacist if you notice the signs and symptoms of an overdose . before you use this nasal spray , take it at least 2 to 3 hours before using a new nasal spray . always use this medicine exactly as your doctor has told you . check with your doctor
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . if you have symptoms such as : - shoulders , ears , breastbone , sternum , ear , fingernail . - clear the mouth and nose of any blockers . - breathe in through the mouth or nose . see section 1 . breathing is the chest moving through the chest . you can hear breathing sounds and breath on the cheek . overdose may occur if your response to touch or sounds is slow uneven breathing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : acute withdrawal symptoms may be associated with opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . these are uncommon ( may affect up to 1 in 100 people ). if you experience any of these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . one dose of each nasal spray contains 1 . 8 mg . - the other ingredients ( excipients ) are hydrochloride dihydrate , trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide and purified water . the recommended dose for adults , adolescents and children aged 0 . 1 years and above is one spray in a pre - filled nasal spray . a single dose container contains one spray to be used in the morning and one in the evening . not all pack sizes may be marketed . nyx
what ovaleap is this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that stimulates the growth of the cells ( follicles ) in the ovaries ). it is used for the production of sperm ( a mature egg cell ) after treatment with a medicine called " clomifene citrate ". this medicine is used in assisted reproductive technology procedures ( e . g ., procedures to make a baby ) to help you become pregnant . it is also used in women who are unable to take a medicine known as " lutropin alkfa " or
do not use ovaleap if you are allergic to follitropin alfa , a type of follicle stimulating hormone , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a tumour in your hypothalamus or pituitary gland ( part of the brain ), large ovaries or sacs of fluids in the ovaries . ovarian cysts . unexplained vaginal bleeding . cancer in your ovaries , womb or breasts . any condition that makes normal pregnancy impossible . ovarian failure in early menopause . fibroid tumours of the womb . malformed reproductive organs . testicular failure
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of this medicine is one injection into the tissue under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how long you should use the medicine . if you use more ovaleap than you should if you inject too much this medicine , contact your doctor . the usual starting dose is 75 mg once a day . this medicine may be given
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 uncommon ( may affect up to 1 in 10 , 000 people ): - if you experience this type of reaction , stop your ovaleap injection immediately and contact your doctor or pharmacist immediately . - other side effects in women lower stomach ache , nausea and vomiting . the symptoms of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored at room temperature ( up to 3 ) for up to 25 days . once this medicine has been removed from the refrigerator and is ready to be used , it must be used within 3 days . if it has been frozen for more than 3 days , the cartridge must be put back in the refrigerator
what ovaleap contains the active substance is follitropin alfa . each ml of solution for injection ( injection ) contains 300 micrograms ( 0 . 5 ml ) of solution . each vial contains 22 milligrams ( 23 million iu ) of the other ingredients ( listed in section 6 ). the recommended dose ( for use in children and adolescents aged 22 years and above ) is one milligram ( i . e ., one millilitre ) of follitonropin alpha . each carton contains one vial of 0 . 75 ml solution . after each injection , each cartridge contains 900 micro
voriconazole accord is an antifungal medicine that works by stopping the growth of the fungus that causes infections . it is used to treat invasive aspergillosis ( a type of fungal infection ) in adults , adolescents and children aged 2 years and older . it can also be used in the treatment of invasive aminotransferase ( an invasive form of the fungi that causes candida sp ) in non - neutropenic patients , who have abnormally low white blood cells count ( a condition in which the immune system ( the body ' s natural defence system ) is unable to fight off candid
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any other medicines , including herbal medicines . the medicines listed below may affect the way your doctor or nurse works . if any of these apply to you ( or you are not sure ), tell your doctor straight away . before you are given this medicine , your doctor will tell you whether you should take : 46 terfenadine if you have a history of allergy to astemizole if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is based on your weight and the type of infection you have . the usual starting dose is 40 mg twice a day . this will be increased to 40 mg once a day for 24 hours . your doctor may increase your dose to 400 mg two times a day ( for 12 hours ) and to 200 mg once every 24 hours ). the recommended maintenance dose is one 100 mg tablet per day . depending on how you respond to treatment , the doctor may prescribe a lower dose of 300 mg . if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any side effects not listed in this leaflet . serious side effects that have been reported with voriconazole accord include rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual
what voriconazole accord contains the active substance is voricazole . each 50 mg film - coated tablet contains either 50 mg or 200 mg . the other ingredients are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . the tablet coating contains hypromellose , titanium dioxide ( e171 ), lactosemonohydrate , triacetin . the film - coating contains a clear , colourless to pale yellow substance ( e172 ) and is printed with the company logo on one side and plain on the other . what v
mvabea is a vaccine used to prevent ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older . the recommended dose is one dose ( 0 . 5 ml ) to be given by a doctor who is experienced in the protection of ebola viruses . your doctor will give you a 2 - dose course of vaccinations to prevent thezaire ebolavirus and filovirus from spreading to other parts of the body . this vaccine contains less than 1 % of the active substance of the zabdeno vaccine . if you are not sure , talk to
follow carefully all instructions given to you by your doctor or nurse . the vaccination course should be initiated by a doctor experienced in the use of the vaccine . if you have ever had a severe allergic reaction to an antibiotic called ' gentamicin ' or any of the other ingredients in the vaccine ( listed in section 6 . warnings and precautions talk to your doctor , nurse or pharmacist before you are given mvabea , or if you are at risk of having a severe allergy reaction to any other vaccine injection . fainted during the injection , bleeding or bruise easily if you currently have a fever or an infection . medicines that
your doctor or nurse will give you the vaccine by injection into a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose of vaccination is one zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine should be given at the same time as the first . your doctor will tell you how many doses of vaccine you should receive . primary vaccination first vaccination followed by a second vaccination . second vaccination following the first vaccination with zab deno , the second vaccination should not be given until at least 8 weeks after the first
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth or swelling at the site of the injection very tired muscle ache joint pain common : may affect up to 1in 10 people : feeling sick ( vomiting ) itching after the injection uncommon : may affects up to one in 100 people : redness or skin hardness at the place of thejection generalised itching . the most common side effects reported in children and adolescents from 1 to 17 years of age : common :
what mvabea contains - the active substance is zaire ebolavirus 29 . one ml of solution contains tai forest orbiolavirus nucleoprotein marburg equivalent to 0 . 7 mg / 108 micrograms . - the other ingredients are : chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what mvoabea looks like and contents of the pack the vaccine is a suspension for injection in a single - dose glass vial with a rubber stopper
ondronat contains the active substance ibandronic acid , which belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones called ' bone ametastases '. it prevents your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat works by reducing the amount of calcium in your blood . this reduces the risk of a tumour that is lost from your bones and makes your bones weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have ever had or might now have a side effect called osteonecrosis of the jaw ( onj ). onj is a form of bone damage in the jaw . your doctor may need to adjust your dose or stop your treatment if you think you may be at risk of developing onj . you have cancer or related conditions
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have cancer , your doctor will give you an infusion into your vein every 3 - 4 weeks . this will be given as an infusion in your vein over a period of 15 minutes with a raised calcium level in your blood . this may be repeated every 1 to 2 weeks . if your doctor determines that the effect of the medicine is too strong or too weak , he or she may decide to increase your dose or stop it altogether . your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you may need urgent medical treatment : very common ( may affect more than 1 in 1 , 000 people ): persistent eye pain inflammation new pain or weakness or discomfort in your thigh , hip or groin . unusual fracture of the thigh bone . common : may affect up to 1 in 10 , 000 users : pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue that lines the jaw and bone ). ear pain or discharge from the ear . these may be signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . after dilution the infusion solution should be used within 24 hours . this medicine does not require any special storage conditions .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion ( equivalent to 2 mg iibandronic acid ). - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondsronat looks like and contents of the pack this medicine is a clear , colourless to pale yellow solution . it is supplied in packs containing 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
zeposia is a type of medicine that works by stopping the growth of certain types of white blood cells ( lymphocytes ) which are involved in the process of relapsing remitting multiple sclerosis ( rms ). rms is an active disease that affects the nerves of the brain and spinal cord . symptoms may include numbness , difficulty in walking , and problems with vision and balance . the symptoms usually disappear within a few periods . some problems may be life - threatening . if you have any questions about why this medicine has been prescribed for you , ask your doctor or pharmacist .
do not take zeposia if you are allergic to zanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke or transient ischemic attack ). warnings and precautions talk to your doctor , pharmacist or nurse before you start treatment if : you have severe heart failure in the last 6 months . you have irregular or abnormal heartbeats ( arrhythmia ). your heart is not working properly during treatment . you suffer from severe infection such as hepatitis , tuberculosis or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zeposia is based on your heart rate . your doctor will prescribe you a ' treatment initiation pack ' for treatment . the recommended starting dose is 4 mg ( 0 . 23 mg ozanimod ) once a day . this will be followed by 1 mg ( 4 mg ) twice a day for 4 weeks . treatment will be continued for 3 weeks at a maximum of 0 . 46 mg / m2 body weight . if you take more zepnosia
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( blood pressure may increase up to 1 in 100 people ): allergic reaction . the signs may include a rash . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . keep this medicine in the original package in order to protect from light . this medicine does not require any special temperature storage conditions . if you notice any damage to the pack , tell your pharmacist .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg / ml of solution for injection . - the other ingredients are : capsule contents : 0 . 22 mg hydrochloride ( see end of this leaflet for further information on the contents of the pack ). the capsule size is 0 . 46 mm in diameter , with a diameter of 0 . 45 mm . ozanimog is supplied in a glass vial containing 0 . 48 mm of solution . - capsule shell : microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide , vilanterol and flitasone fluorate . these belong to a group of medicines called corticosteroids . steroids are substances produced by the body that help to control the amount of fluid in your body ( called " fluid in the lungs ") and which can be taken orally or in combination with other medicines called bronchodilators ( such as temybaxta ). the active substance in temyboxta is used to treat chronic obstructive pulmonary
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor straight away . if you have asthma , your doctor may need to adjust your dose or stop you while you are being treated . your doctor should tell you if you suffer from asthma , heart problems , high blood pressure , liver problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . swallow the tablet whole with a glass of water . you can take temybric ellipta with or without food . take the tablet at about the same time each day . do not take more than one tablet a day for 24 hours . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing does not improve after taking this medicine , tell your doctor straight away . pneumonia is an infection of the lung ( copd ). the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore , raised patches in the mouth or throat , a fungal infection ( candidiasis
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhalation contains 92 micrograms ( 1 . 5 millilitres ). - the other ingredients ( excipients ) in the inhaler are : tablet core ( e460b ) : one tablet ( e464b ) contains 65 microlitres ( umclidinicium ) and two tablets ( e470b ) containing 55 microlitre ( umecylidinIUM ) and 22 microliters ( e468b
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues around the skin . it is used to treat an infection of the lungs known as ' pneumonia ' that has spread to other parts of the body . it works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . warnings and precautions talk to your doctor , pharmacist or nurse before taking zin foro if : you have kidney problems . you have ever had seizures or convulsions . you suffer from any non - severe allergic reaction to any other antibiotics ( e . g . pen
always take zinforo exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 600 mg once a day for 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks . if you have some infections that have not responded to treatment for 8 weeks or 12 weeks , your doctor will give you a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . if your doctor thinks that the effect of the drip is too strong or too weak , you may be given 120 mg twice a day
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - sudden swelling of your lips , face , throat or tongue . - a severe rash . - swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). - diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to stop you taking medicines that slow bowel movement ( see section 1 ). - a blood test called a 'ombs test
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 30 . store in the original package in order to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is 600 mg ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for solution for infusion in a vial . each pack contains 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain is a form of long lasting pain caused by damage to the nerves . a variety of diseases have been associated with peripheral neurological pain , such as diabetes , shingles , pain sensations such as burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling or numbness , pins and needles . in patients with peripheral and peripheral neuropathicpain , mood changes , sleep disturbance , fatigue and tiredness have been
do not take pregabalin pfizer : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . before you are given pregagalin pumpfizer , tell your doctor or pharmacist if you : - have symptoms of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . these reactions are usually mild to moderate . - have previously experienced dizziness or somnolence , which may be a sign of accidental injury
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is used to treat peripheral and central neuropathic pain ( epilepsy ) and generalised anxiety disorder in adults . the recommended dose is 150 mg twice a day . your doctor may increase your dose to 600 mg once a day depending on how you respond to the medicine . you should swallow the capsule whole with a glass of water . do not crush or chew the capsule . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache common : may affect up to 1in 10 people : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with
what pregabalin pfizer contains - the active substance is preguabalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of preguibalin . - the other ingredients are lactose monohydrate , maize starch , talc , gelatin , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac , black iron oxide ( e172 ), propylene glycol , potassium hydroxide ). - the 75 mg and 100 mg hard capsules are
xadago is a medicine that contains the active substance safinamide , which blocks the action of dopamine in the brain . it is used to treat parkinson ' s disease in adults , adolescents and children aged 2 years and older . xadago works by reducing the amount of dopamine that is released from the brain into the body . it has been shown to improve the ability to move and reduce the risk of difficulties moving .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , tranylcypromine ( for treatment of parkinson ' s disease or depression ). pethidine ( a strong pain killer ). see section 7 " warnings and precautions " at the end of this leaflet for further information .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose of xadago is 50 mg twice a day . this may be increased to 100 mg once a day by mouth . your doctor will tell you how many tablets to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg per day . if this is not possible , take your next dose at the usual time . swallow the tablets whole with a glass of water . do not chew or crush the tablets . if your doctor advises you to take
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure which can lead to collapse ). neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). confusion , hypertension , muscle stiffness and hallucinations ( hypotension ). the following side effects have been reported with parkinson ' s disease in combination with safinamide and levodopa . other medicines and xadago tell your doctor or pharmacist if you are taking , have recently taken or might take any
what xadago contains - the active substance is safinamide . each tablet contains either 50 mg or 100 mg . - the other ingredients in the tablet core are : tablet core : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate . tablet coat : silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ), and talc ( e553b ). what xadagon looks like and contents of the packxadago 50 mg film -
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the amount of testosterone in your body . this results in a lowering of the level of testosterone that is needed to fight prostate cancer .
do not take zytiga if : you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant . you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking ztiga if you have severe liver damage . you have prostate cancer . you should not take this medicine unless your doctor tells you to . if you are taking this medicine for the treatment of liver problems , such as high blood pressure , heart failure , low blood potassium , heart rhythm problems , other heart or blood vessel problems , an irregular or rapid heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 1 , 000 mg tablet once a day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more zytiga than you should if you accidentally take too many tablets of this medicine , talk to a doctor or go to the nearest hospital straight away . take the tablet with food . take it with or without water . it is best to take it at least one hour before or one hour after a meal . you can take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor will check your potassium regularly . other possible side effects may include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet . low blood potassium ( shown in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common ( might affect up to 1 in 100 people ): high
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate ( as monohydrate ). - the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see end of section 2 for further information on the contents of the pack - zytigo tablets are supplied in a 9 . 5 ml plastic bottle with a child - resistant closure . each
hefiya contains the active substance adalimumab . it is a medicine that is used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease . paediatric non - infectious uveitis is a disease in which the immune system ( the body ' s natural defence system ) does not produce enough of a monoclonal antibody ( a type of immune system ) to fight off the inflammatory diseases . the inflammation in these diseases is most common in patients of all ages , including polyart
do not take hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . unusual infections may be a sign of a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . if any of these apply to you , tell your doctor . allergic reaction allergic reactions include symptoms such as chest tightness , wheezing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take . the usual starting dose is 20 mg twice a day ( two 40 mg tablets ). your doctor may increase your dose to a maximum of 20 mg two days a week . for polyarticular juvenile idiopathic arthritis age ( body weight ) the recommended daily dose is 2 tablets ( 30 mg ) two times a day , two tablets ( 40 mg ) and one tablet ( 20 mg )
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 4 people ) - after the last hefiya injection - allergic reaction - heart failure - severe rash , hives , swollen face , hands , feet - trouble breathing or swallowing - shortness of breath - swelling of the feet - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a period of up to 14 days . once the product has been opened , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 micrograms of adhalimumab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide . - water for injections . what hefaya looks like and contents of the pack heifaya is a clear , colourless to slightly yellowish solution supplied in a clear type i glass syringe with a stainlessless steel needle and a needle guard
what ritemvia is rituximab is a type of medicine known as a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocytes ". it works by blocking the action of a protein called " monocyte - colony stimulating factor ", which is involved in the growth and spread of cells in the body . by attaching to this protein it allows the immune system ( the body ' s natural defence system ) to increase the number of cells that are affected by the disease . this allows the body to produce more of these cells , called " white blood cells " ( b
do not take ritemvia : - if you are allergic to rituximab , other proteins that contain the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents below 6 years of age because there is not enough information available on its use in this age group . there is limited information on the use of
always use ritemvia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this treatment will be given to you by a doctor or nurse experienced in the use of this medicine . if you experience any side effects , talk to your doctor , pharmacist or nurse . the recommended dose is one tablet once a day ( intravenous infusion ). your doctor may prescribe medicines for each ritemvia administration . your doctor will tell you how many tablets to take . you may need to take other medicines ( pre - medication ) to reduce the risk of possible side effects during your treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as 10 mg / ml ). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . - the solvent is a clear , colourless solution for infusion in a glass vial . see section 2 for further information .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ". they work by stopping the growth of cancer cells in the body , which can then be killed by the immune system ( the body ' s natural defence system ) and by stopping them from growing . capecitabrine teva is used in adults to treat adult patients with a type of colon , rectal , gastric , or breast cancers that have spread to other parts of the body ( called " colon cancer "). complete removal of the tumour from the body after surgery has been performed . if you have any further questions on the
do not take capecitabine teva : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor if you think you may have an allergy to this medicine . severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines called fluorouracil ) have been reported in pregnant women . low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ). severe liver or kidney problems . the enzyme dihydropyrimidine dehydrogenase ( dpd
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine belongs to a group of anticancer medicines called " anti - fungal medicines ". a dose and treatment regimen is based on your body surface area ( height ) and weight . the recommended dose is 1250 mg twice a day . your doctor will tell you how many tablets to take . the usual dose is one tablet once a day ( two tablets in the morning and one tablet in the evening ). the dose may be increased or decreased depending on body weight , height , weight and body surface
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you experience any of these symptoms : diarrhoea ( an increase of 4 or more bowel movements ) at night . vomiting ( nausea ) if you lose your appetite . stomatitis ( pain , redness , swelling or sores in your mouth and / or throat , especially in your hand or foot ). skin - reaction : pain , swelling and redness or tingling of hands and /or feet fever ( up to 38 ). infection : infection caused by bacteria
what capecitabine teva contains - the active substance is ciclabine . each film - coated tablet contains 150 mg of cicllabine ( as 150 mg ). - the other ingredients are lactose , microcrystalline cellulose ( e460 ), hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 ( e553b ). - tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide [ e172 ] ( see end of this leaflet for further information ). what capecit
silodosin recordati is a medicine that belongs to a group of medicines called alpha1a - adrenoreceptor blockers . it works by blocking the activity of these receptors in the prostate , bladder and urethra . this helps to maintain a smooth muscle in these tissues . it also reduces your symptoms . what is silodosic recordati used for silosinrecordati is used to treat the urinary symptoms associated with benign enlargement of the prostate ( also known as prostatic hyperplasia ). this can cause difficulty in starting to pass water or a feeling of not completely emptying the bladder .
do not take silodosin recordati : - if you are allergic to silosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you have had eye surgery or cloudiness of the lens at the site of cataract surgery . the recommended dose is 26 mg / m2 of body surface area per day . if any of these apply to you , tell your doctor or pharmacist . you should not have to take any more than prescribed by your doctor . if your doctor thinks that the effect of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is 8 mg once a day . if you have kidney problems or moderate kidney problems , your doctor may prescribe a lower dose . take this dose at the same time each day . swallow the capsule whole with a glass of water . do not crush or chew the capsule . you can take it with or without food . take it at any time of the day , even when you feel dizzy or feel weak . take the capsule with you . take silod
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint or itchy skin , hives are the most common side effect of silodosin recordati . dizziness or dizziness , occasionally fainting . if you feel weak or dizzy , tell your doctor straight away . if the symptoms of dizziness are severe , talk to your doctor or pharmacist straight away ( see section " possible side effects "). if you are having a cataract surgery or eye surgery , you may experience cloudiness of the
what silodosin recordati contains - the active substance is silosin . each hard capsule contains 8 mg of siliodosin ( as 8 mg ). - the other ingredients are : capsule content : mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : shellac , white , opaque , hard gelatin capsules , imprinted with " s " on one side and " 4 " on the other side . printing ink : silodosein . capsule shells : pregelatinised , capsule shaped , hard capsule contents : capsule shape : man
kinzalmono belongs to a group of medicines called angiotensin ii receptor antagonists ( angi ) and works by allowing the body ' s blood vessels to narrow . this allows your blood pressure to be lowered . by blocking the effect of angi , the blood vessels relax . this lowers the amount of blood pressure in your body and increases your ability to carry out normal daily activities . this is called essential hypertension ( high blood pressure ). it is important that you keep following the advice given to you by your doctor or pharmacist . if you have any of the above , talk to your doctor , pharmacist or nurse
do not take kinzalmono if : you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). you are more than 3 months pregnant . if you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking kinzdalmono . during pregnancy and during the pregnancy section , you should tell your doctor if you : have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ). have any other severe liver disease . have diabetes . have impaired
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . swallow the tablet whole with a glass of water . take the tablets at the same time each day . the tablet can be taken with or without food . your doctor will tell you how many tablets to take . do not take a double dose to make up for a forgotten tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : sepsis ( blood poisoning ), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). if any of the side effects gets serious , stop taking kinzalmono and talk to your doctor or pharmacist . if you get any side effects not listed in this leaflet , you can also report side effects directly via the national reporting system listed in appendix
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . keep your medicine in the outer carton in order to protect from light . once your kinzalmono tablet has been removed from the blister , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa , which belongs to a group of medicines called cytokines , and is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v ii deficiency ). factor v iii is involved in blood clotting and helps to clot the blood . an increased tendency to bleed is due to the lack of factor iii in the blood , which is a condition in which the immune system ( the body ' s natural defence system ) does not clot properly . afstyl
do not use afstyla : - if you have ever had an allergic reaction to hamster proteins 46 if you are not sure , talk to your doctor or pharmacist . warnings and precautions tell your doctor , pharmacist or nurse immediately if you experience any of the following symptoms of allergic reactions : - allergic reactions ( hives ) - generalised skin rash - tightness of the chest - wheezing - fall in blood pressure ( anaphylaxis ) - a serious allergic reaction that may cause severe difficulty in breathing or dizziness . inhibitors ( antibodies ) are a known complication in all factor viii medicines . these
your treatment will be supervised by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of afstyla depends on the severity of your disease the site of administration and the bleeding your clinical condition . after reconstitution and administration general instructions the powder , the solvent ( liquid ) and aseptic conditions should be used immediately after administration . if you have not been trained in the care of other medicines or solvents , please read section 6 . the solution should be clear to
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding caused by factor viii medicines ). inhibitor antibodies ( see section 2 " warnings and precautions "). common side effects ( may affect up to 1 in 10 people ) in patients receiving previous treatment with factor v iii ( less than 150 days of treatment ) in combination with medicines to prevent persistent bleeding .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user .
what afstyla contains - the active substance is lonoctocog alfa . each vial contains 250 micrograms of 2 . 5 ml of solution for injection . - the other ingredients are : - injections the solution contains 100 microlitres ( i . e ., the other ingredient in the vial ) ( see section 2 ). after reconstitution , the recommended dose is : - two doses ( two injections per day ). - one injection per day . - two injections each day ( one injection each day ) ( one infusion each day ). this is to make sure that the solution is clear and colour
what praxbind is and what it is used for the active substance is idarucizumab ( also known as dabigatran ( pradaxa ). it is a blood thinner medicine used to prevent blood clot formation in adults . what is it used for ? when used in adults , it is given to you by a doctor or nurse as a reverse agent . it works by blocking the action of a substance in your body called " dabigitran " which can be used as a blood thinning medicine . this reduces the risk of blood clotformation . when used to treat blood clots , prax
do not take praxbind - if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have a genetic disease called hereditary fructose intolerance ( hafr ). this medicine contains the substance sorbitol . this medicine can cause serious adverse reactions . do not take this medicine with dabigatran or other medicines that may increase the risk of blood clots ( see section " other medicines and praxbind "). dabigitran is a naturally occurring substance in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 5 mg ( 2 . 5 mg ) dabigatran per kilogram of body weight . this medicine will be given to you by a doctor or nurse . if you have any further questions on the use of this medicine , ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with praxbind : reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what Praxbind looks like and contents of the pack the clear , colourless to slightly opalescent , slightly yellow solution with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat the following types of brain tumours : - newly - diagnosed glioblastoma multiforme ( gli ) in adults , adolescents and children aged 3 years and older : - malignant glioma ( also known as gliOBlastoma multififorme ) in adult patients , and - anaplastic astrocytoma ( a type of tumour ) in children aged 2 to 17 years with standard treatment .
do not take temomedac : if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine ) or dtic . if you experience signs of allergic reaction such as feeling itchy , breathlessness , wheezing or swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ). if your white blood cell count ( platelet count ) is too low . these blood cells help you in fighting infection . proper blood clot
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment the recommended dose of temomedac is based on your height and weight . if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may give you other medicines ( anti - emetics ) to reduce the risk of nausea and vomiting . in patients with newly - diagnosed glioblastoma multiforme , the recommended starting dose is one tablet once a day . treatment will be followed by treatment with radiotherapy ( concomitant phase
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction such as hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills , severe headache , temomedac treatment may result in a reduction in certain kinds of blood cells , increased bruising and bleeding ( anaemia ), reduction in the number of red blood cells and fever , reduced resistance to infections . the reduction in blood cell counts may lead to anaemia ( aplastic anaemia ) in your blood . your doctor may prescribe specific
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . once removed from the refrigerator , temomedac should be used within 30 days without any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . each capsule of temomedic 5 mg contains 5 mg of temozolsomide ( see section 2 ). - the other ingredients are : capsule contents : gelatin , titanium dioxide ( e 171 ), shellac , propylene glycol ( e 132 ), yellow iron oxide ( e 172 ) in the capsule shell ( including printing ink ). capsule shell : tablet core : anhydrous lactose ( e 421 ), colloidal ahydrous silica ( e 422 ), sodium starch glycolate type a , tartaric acid , stearic acid
cialis is a treatment for adult men with erectile dysfunction who cannot get a hard erect penis suitable for sexual activity . cialis works by blocking the action of a substance called tadalafil , which belongs to a group of medicines known as phosphodiesterase type 5 inhibitors . this is a substance that binds to receptors in the blood vessels of the penis causing them to tighten . this makes the penis to tighten , thus increasing the amount of blood in the penis . this helps to maintain erectile function . if you are not sure , talk to your doctor , pharmacist or nurse before you are given cial
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines . the use of nitrate is not recommended in patients with serious heart disease . if you have recently had a heart attack in the last 90 days . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take cialis tablets at the same time each day . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the recommended starting dose is 5 mg twice a day . your doctor may increase your dose to 2 . 5 mg once a day depending on how you respond to the medicine . do not take more than the recommended daily dose . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain common ( may affect up to 1 in 10 people ) nitrates ( frequency cannot be estimated from the available data ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and see your doctor straight away if you notice any of the following : very common : may affect more than 1 in 100 people headache back pain muscle aches pain in arms and legs facial flushing nasal congestion indigestion common
what cialis contains - the active substance is tadalafil . each 2 . 5 mg film - coated tablet contains one tablet ( tablet ) containing two tablets ( tablet ). - the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ). tablet coating : croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ) and iron oxide red ( e
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas produce more insulin to control your blood sugar ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin when the sugar in your blood is too high or too low . the insulin that your body produces does not work as well as it should and it can cause problems with your body ' s ability to make the insulin it needs to make it work properly . when treatment is started , diet and exercise and weight reduction are taken to control the blood sugar . en
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high . warnings and precautions diabetic ketoacidosis is a severe liver disease . gemfibrozil is a medicine used to lower increased fat levels in the blood . it is used to treat liver problems in adult patients with moderate liver 28 disease . see also section 2 . if you think you may be taking eneyglid , talk to your doctor before taking it . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . it is best to take it at least 30 minutes before or at least 4 hours after food . take the tablet at about the same time each day . do not take a double dose to make up for a forgotten tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of enyglid . it is very common ( may affect more than 1 in 10 people ) in patients treated with this medicine . the following symptoms are generally mild / moderate , but may occasionally be severe . if this happens to you , you should contact your doctor straightaway ( see section 2 " warnings and precautions "). if you notice any of these symptoms : swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects common
what enyglid contains - the active substance is repaglinide . each vial contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) ( see section 1 ). tablet coating : white , round and biconvex with bevelled edges . see section 2 " en
azacitidine mylan is an anti - cancer agent . it contains the active substance azapitidine .
you must not be given azacitidine mylan : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may experience decreased counts of platelets , a type of red or white blood cells . if you suffer from kidney disease , liver disease or a heart condition ( e . g . heart attack or lung disease ). your doctor will do blood test before you start treatment . you should tell your doctor if you think you have been given too much azac
azacitidine mylan will be given to you by a doctor or nurse who is experienced in the use of another medicine to treat nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . the usual starting dose of azacitine mylan is 3 mg once daily . this " treatment cycle " will be repeated every 4 to 6 weeks . this medicine is given under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : drowsiness , shaking , jaundice , abdominal bloating , easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these are symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain , shortness
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine in the original package in order to protect from light . the suspension may be stored at room temperature ( up to 1 ) for a single period of up to a maximum of one month . after reconstitution with water for injections , the suspension can be stored for up to 8 hours at
what azacitidine mylan contains - the active substance is azapitidine . one vial of powder contains 100 milligrams of azacinidine . after reconstitution , each vial contains 4 ml of water for injections . - the reconstituted suspension contains 25 mg / ml ( 0 . 5 %) of azaxitidine ( as mannitol ). - the other ingredients are : powder for concentrate for solution for injection ( see section 4 ). powder for solvent ( solvent for injections ) for solvent for injection . see section 25 for further information . - solvent for solvent . - azac
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue . it works by blocking the flow of fluid from the eye to the eye through a membrane called a beta blocker . this reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in the eye in adults with an illness called glaucoma .
do not take duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis , severe lung disease , wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever and a slow heartbeat . if you suffer from heart failure ( a disorder of heart rhythm , irregular heartbeat ), your eye may become cloudy . warnings and precautions talk to your doctor or pharmacist before you are given duot
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in each eye each day . do not use more than one drop of duotrav in the same day . make sure that your eyes are covered with a clear , colourless , soft contact lens . if you have any further questions on the use of this medicine , ask your doctor . how to use your eye drops the recommended starting dose is 1 drop in the morning , 2 drops in the evening , 3 times a day , and 4 times a
like all medicines , this medicine can cause side effects , although not everybody gets them . always use the drops exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . duotrav can cause very common side effects ( may affect more than 1 in 10 people ). the eye eye redness is very common . it may affect up to 1 in every 10 people . the eye surface inflammation ( surface damage ) can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms include eye irritation , burning or stinging . uncommon side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 4 hours at room temperature to prevent infections .
what duotrav contains - the active substance is travoprost . each vial contains timolol 40 mg . each ml of solution contains trifampicin 5 mg / ml . - the other ingredients in the vial are : - the excipients of the product ( s ) are : tablet core : timolole maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg tablet coating : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid . - purified water : sodium hyd
what nplate is nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets accumulate in your blood and help to prevent blood clots from forming . itp can be very serious and can lead to very lowplatelet counts , bruising and serious bleeding . it may affect up to 1 in 10 people with spleen removed . if you have chronic
do not take nplate : if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other medicines containing escherichia coli ( e . coli ). warnings and precautions talk to your doctor , pharmacist or nurse before taking nplate . if you have a low blood platelet count ( thrombocytopenia ). if this applies to you , tell your doctor straight away . nplate may increase yourplatelet count , which may increase the risk of blood clots forming . if this happens , your doctor may
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents from 1 month to 17 years of age the recommended dose of nplate is one injection under the skin ( subcutaneous ). your doctor will tell you how much nplate to use . how often to inject nplate you will need to check your platelet counts regularly . regular blood samples will be taken to measure the number of your platelets in your blood . your doctor may also check your blood platelet count regularly . the usual starting dose is 1 mg once a day . children from
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( likely to affect up to 1 in 100 people ): bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine in the outer carton in order to protect from light . once removed from the refrigerator , it should be used within 30 days .
what nplate contains - the active substance is romiplostim . each vial of nplate 125 mg solution for injection contains 230 mg ( 1 , 000 iu ). - the other ingredients ( excipients ) are : nplate 250 mg ( 2 , 400 iu ) romiplopim and a deliverable amount of 0 . 25 ml solution . each ml of solution contains 125 mg ( 3 , 375 iu ), romiplothim and 500 mg ( 4 , 600 iu), respectively . nplate 750 mg ( 6 , 500 iu ): the other ingredient is : tablet core : romplost
this medicine contains an active substance called glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd is a condition in which the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles , making it easier for air to get in and out of the lungs . this helps to reduce the amount of air that leaves the lungs and makes breathing easier for you .
do not take tovanor breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma - have difficulty passing urine . your doctor may decide to delay or stop treatment if this applies to you . if you have any further questions on the use , ask your doctor or pharmacist . if any of these apply to you , tell your doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one capsule once a day . this medicine may be used for up to 24 hours at room temperature ( up to 75 ). if you use more than one capsule a day , your doctor may tell you to stop using this medicine . how to use to take this medicine use an inhaler and capsules ( in blisters ). the medicine contains inhalation powder . the capsules should be swallowed whole with
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 23 milligrams ) glycoprroniumbromide , equivalent to 50 microg / ml . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . see the end of this leaflet for further information on the contents of the inhaler . what toivanor breezyhaler looks like and content of the pack tovanor breezehaler 44 mg hard capsules are white to off - white powder
adasuve contains the active substance loxapine , which belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce more dopamine and serotonin , which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in schizophrenia and bipolar disorder ( diseases characterised by symptoms such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , feeling depressed , guilty , anxious , tense , bipolar disorder , feeling " high ", excessive amounts of energy , needing much less sleep than usual , racing ideas
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adsasuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or shortness of breath 25 you have neuroleptic malignant syndrome ( nms ). these are symptoms of antipsychotic medicines . these symptoms include high fever , rigid muscles 47 you have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 9 . 1 mg twice a day for 2 weeks , followed by 4 . 5 mg once a day . if your condition worsens , your doctor may prescribe a lower dose . always take adasuve by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you have any further questions on the use of this medicine , ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness or irritating in your airways ( asthma or copd ), light - headedness or fainting . these may be signs of worsening agitation , confusion , fever and muscle stiffness . this is a severe condition known as neuroleptic malignant syndrome . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): taste in the mouth or sleepiness ( common ) common
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . if you have any further questions on the use of this product , ask your pharmacist .
always use adasuve exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for each single - dose inhaler is 5 mg of loxapine per day . your doctor delivers one 4 . 5 mg inhalation per day with or without food . do not change the dose unless your doctor tells you to . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
azacitidine betapharm is an anti - cancer agent . it belongs to a group of medicines called " medicines for the treatment of cancer ". how and when to take the tablet ? your doctor or pharmacist will tell you how many tablets to take . the recommended dose is one tablet once a day . the tablet can be taken with or without food . swallow the tablet whole with a glass of water . do not chew or crush the tablet . how to take and how long it takes to take your tablet to take it the tablet should be taken at least one hour before or one hour after a stem cell transplantation .
you must not be given azacitidine betapharm : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , tell your doctor as soon as possible . you may experience decreased counts of platelets ( a type of red or white blood cells ), which are important in the treatment of kidney disease . patients with liver disease have a heart condition known as heart attack or lung disease . your doctor will do blood test
azacitidine betapharm will be given to you by a doctor or nurse as another medicine to treat nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . the doctor will also tell you the type of medicine you are taking . the usual dose is one tablet a day for 3 days . this " treatment cycle " will be repeated every 4 to 6 weeks . this medicine is given under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : drowsiness , shaking , jaundice , abdominal bloating , easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these are symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain , shortness
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . the suspension can be stored at room temperature ( up to 45 ) for up to a single period of up to one month . after reconstitution with water for injections , the suspension should be used within 8 hours . if not used immediately , in - use storage times and conditions prior to use are the
what azacitidine betapharm contains - the active substance is azapitidine . each vial contains 100 mg of azapanidine . after reconstitution , each ml of solution contains 4 mg of water for injections . the reconstituted suspension contains 25 mg / ml of azacetidine . - the other ingredients are mannitol ( e421 ) and sodium ( e1520 ) ( see end of section 2 ). - the solvent is clear , colourless to pale yellow and contains no visible particulate matter ( e172 ) and is clear to opalescent and colourless . what azac
cedelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults , adolescents and children aged 1 year and older with a certain inherited condition called glucosylceramide . it works by reducing the amount of sugar in your body , especially in the spleen , liver and bones . your doctor will tell you how long you should continue to take this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking cerdelga . slow speed
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 you have been taking moderatecyp3a inhibitors such as erythromycin or itraconazole . these medicines have been shown to affect your body ' s ability to use them . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Cerdelga . if you are not sure , talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of metaboliser per day . swallow the tablet whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . your doctor will tell you how many tablets to take . how much to take the recommended daily dose is 84 mg . take the tablet at the same time each day . do not take more than one tablet in the morning or two tablets in
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting , dry mouth gas ( flat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . this medicinal product does not require any special storage conditions .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of this medicine . - the other ingredients are : capsule content : microcrystalline cellulose ( e460 ), lactose monohydrate ( see section 2 for further information on lactose '). capsule shell : hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine , shellac , black iron oxide , propylene glycol and ammonia solution ( see also section 4 for more information on what cerdel
the active substance in zoledronic acid hospira is bisphosphonates , a substance produced in the body that binds to receptors in the bone and causes bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( a type of cancer that affects the primary site of the bone ). it works by reducing the amount of calcium in the blood . this is called tumour - induced hypercalcaemia ( tih ).
your doctor will carry out blood tests before and during treatment with zoledronic acid hospira . the results of these tests will be recorded on the patient alert card and will be given to you by your doctor . if you are not sure , talk to your doctor , pharmacist or nurse before starting treatment . warnings and precautions talk with your doctor or pharmacist before you start treatment if you : - are allergic ( hypersensitive ) to any of the active substances of the medicine ( listed in section 6 ). - are breast - feeding . - have had a kidney problem . - experience pain , swelling or numbness of the jaw ,
always use zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bisphosphonates intravenously ( into a vein ) is for ' iv ' administration . the recommended dose is one tablet once a day , with or without food . your doctor may adjust your dose depending on your condition and on the severity of your kidney problem . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment . your doctor will do blood tests to check for low level of calcium in the blood ( uncommon ) which may be more than 1 in 100 people : pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or feeling of heaviness or loosening of a tooth . these may be signs of bone damage in the jaw ( osteonec
keep this medicine out of the sight and reach of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions .
what zoledronic acid hospira contains - the active substance is zedronic acid . each vial contains one millilitre ( 0 . 5 ml ) of solution for injection . - the other ingredients are : capsule contents : monohydrate , mannitol ( e421 ), sodium citrate and water for injections ( see section 4 for further information on the contents of this pack ). what zolingronic acidic hospira looks like and contents of the pack zoledidronic acid hospira is a liquid concentrate for ' concentrate for solution for infusion ' and ' sterile concentrate '. each pack contains 4 vials of zoled
varuby contains the active substance rolapitant . it is used to treat cancer feeling sick ( nauseous ) or being sick ( vomiting ) at the start of cancer treatment chemotherapy . these nerve cells are involved in the normal functioning of the brain . they help to control the amount of nausea and vomiting that occurs when you are sick . varuby works by reducing the number of these nerve cell cells , which can cause nausea and / or vomiting .
do not take varuby if : you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). you are taking an herbal medicine called st john ' s wort ( hypericum performatum ). you have depression or difficulty sleeping . see section 2 " warnings and precautions " for more information on this medicine . 27 you have severe liver or kidney problems . you have previously taken certain medicines containing rifampicin ( used to treat tuberculosis or other infections ) such as carbamazepine for epilepsy or nerve pain , phenobarbital for epilepsy , enzalutamide
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . take the tablet at least 2 hours before your chemotherapy cycle . if you take more varuby than you should if you have taken too many tablets , talk to a doctor or go to the nearest hospital straight away . your doctor will tell you how many tablets to take and how often to take them . this will help you to remember to take the tablets at the same time each
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very common ( may affect more than 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . contact your doctor immediately if you experience any of these effects . appropriate treatment may be needed . other possible side effects include : common : may affect up to 1 in 10 people : headache constipation feeling tired uncommon : may
what varuby contains - the active substance is rolapitant . each vial contains 90 mg ( 1 . 5 mg ) rolapit . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubsy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . the colour of the
what enerzair breezhaler is the active substance is indacaterol . it belongs to a group of medicines called bronchodilators . it works by tightening the muscles in the lungs . this helps to open the airways and allows the air to flow in and out of the lungs more easily . mometasone furoate is a substance present in a substance called corticosteroids , which are used to reduce the swelling and irritation ( inflammation ) in the small airways in which the lungs are closed . this results in breathing problems and makes it easier for air to get in . cortic
do not take enerzair breezhaler : if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , severe kidney problems , severe liver problems , low level of potassium in your blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler per day . the medicine should be inhaled once a day . always use enerzair breezhaler at the same time each day . it is important that you continue to use it until your asthma has gone away or until your symptoms return . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other possible side effects are listed below . common : may affect up to 1 in every 10 people : sore throat , runny nose , sudden difficulty breathing , feeling of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . keep the capsules in the outer carton in order to protect from light . the capsules should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of unused medicine .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each capsule contains 150 micrograms ( 23 . 5 mg ) of the active substance . the other ingredients are : capsule content : 63 microgram ( 3 . 0 milligrams ) erythromycin ( e1203 ) glycoprronium hydroxyphony ( e903 ) 50 microgram( 3 . 1 milligram ) glyopyrronIUM ( 160 microgram ) momet
clopidogrel acino pharma gmbh contains the active ingredient clopidiogrel , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures that clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombosis ). by reducing the risk of formation of these clots ( thrombi ) they help to protect hardened blood vessels ( arteries ) from the occurrence of atherothrombotic events ( such as stroke , heart attack , or
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . take special care with clop
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . swallow the tablet whole with a glass of water . do not crush or chew the tablet . take the tablet with or without food . if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital emergency department immediately . this will help reduce the risk of bleeding . you should not take more than the recommended daily dose of clop
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 100 people : very rare : may affects up to one in 10 , 000 people : common : 1 in 1 , 000 , not known ( frequency cannot be estimated from the available data ): rare decrease of some blood cells : liver problems : yellowing of the skin or the whites of the eyes ( jaundice ), bleeding under the skin ( red
keep out of the sight and reach of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tablet in the original blister in order to protect from light . after opening the blister , film - coated tablets should be used immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopidoogrel . each tablet contains 75 mg of clopiodogrel ( as monohydrate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ), crospovidone ( a castor oil ). tablet coating : hydrogenated film ( e1203 ), macrogl 6000 ethylcellulose ( e462 ) titanium dioxide ( e171 ) and 171 film - coating : shellac ( e903 ). what clopidiogrel
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. the active substance is doravirine . it is a non - nucleoside reverse transcriptase inhibitor ( nnrti ). the other ingredient is lamivudine , which is also known as " nrti ". it is used in combination with tenofovir disoproxil ( also called " nnnti "). it is also used to prevent aids (' acquired immune deficiency syndrome ') from multiplying
do not take delstrigo : if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : carbamazepine ( used to treat oxcarbazepine ), phenobarbital and phenytoin ( medicines used to prevent seizure ) rifampicin and rifapentine ( medicines to treat tuberculosis ) st . john ' s wort ( hypericum perforatum )
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of a single tablet to treat hiv infection in adults , adolescents and children aged 1 year and above . your doctor may prescribe certain medicines ( such as doravirine or medicines obtained without a prescription ). always take this medicine swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take take del
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests increased levels in liver enzymes uncommon ( might affect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble concentrating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after " exp ". this medicine does not require any special storage conditions . keep the medicine in the bottle tightly closed in order to protect from moisture . the bottle can be kept in the outer carton at room temperature ( not above 25 ). do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains - the active substance is doravirine . each tablet contains 300 mg lamivudine ( equivalent to 245 mg ). - the other ingredients are tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl firarate . - the film - coating material is carnauba wax e903 ( e1521 ). the printing ink contains hypromellaose
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . spravato is used in combination with another antidepressant ( see section 2 under " other antidepressant medicines ").
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack . within 6 weeks of taking this medicine , you may experience a temporary increase in blood pressure . serious complications in these conditions can be life - threatening . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use the spravato nasal spray use the nasal spray device at the same time each day . the recommended dose is 1 inhalation per day , followed by 2 inhalations per day . you can use 3 nasal spray devices in one day . your doctor will tell you how many inhalations you need to use . how long to use one nasal spray should be used every day for at least 4 weeks . if you use more than 4 inhalations , you may need to change the dose of sp
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity to the sun , spinning sensation ( vertigo ), vomiting nausea common : may affect up to 1 in every 10 people : feeling extremely happy , euphoria , feeling agitated , feeling anxious , eyes or ears , sense of touch are distorted or mimicked , irritable panic attacks ( change in perception 37
what spravato contains the active substance is esketamine . one ml of each nasal spray device contains a single - use syringe ( equivalent to 28 milligrams of esketamines ). the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water and water for injections ( see end of section 2 ). what sprovato looks like and contents of the packspravato is a nasal spray solution for injection . this medicine is a clear , colourless solution that is supplied as a single use nasal spraydevice . each box contains one or two nasal spray devices
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body after surgery . melanoma is a type of cancer that arises from a change ( mutation ) in the genes responsible for the growth and spread of melanoma . by attaching itself to proteins that help your cancer grow .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . allergic reactions tell your doctor or pharmacist if you have any allergic reactions . if you experience allergic reactions , tell the doctor or nurse straight away . you may be more likely to develop severe skin reactions if you take more of the medicine than you should
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 4 mg once a day for up to 8 days . if you take more zelboraf than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away ( see section 4 , possible side effects ). your doctor may adjust your dose depending on how you respond to your treatment . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if possible , take it with or without food . if
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation have been reported in patients treated with zelbaf . radiation treatment tell your doctor immediately if you experience any of the following symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever , chills ( pneumonitis ), difficulty or pain when swallowing , chest pain , heartburn , acid reflux ( esophagitis ), any changes in your skin
your doctor , pharmacist or nurse knows how to store zelboraf properly . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 milligrams ( 23 . 5 mg ) of valsartan . - the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). see section 2 for further information on the ingredients of zel
duoplavin contains the active substance clopidogrel , which is acetylsalicylic acid ( arsa ). arsa belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping , the blood vessels relax and become thinner , thus increasing the chances of blood clots forming . atherothrombosis is a condition in which blood vessels become clogged , leading to atheroarthrombotic events ( e . g . stroke , heart attack , or death ). duoplav
do not take duoplavin : if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ), or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other products containing non - steroidal anti - inflammatory products . if you have painful and / or inflammatory conditions of muscles or joints , such as a medical condition called asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ), or if you currently have a risk of bleeding such as : - a stomach ulcer or bleeding within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of duoplavin is one tablet a day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . take your medicine at the same time each day . you may need to take it with or without food . if you have a heart attack , take the tablet with you as soon as you remember . contact your doctor , pharmacist or the nearest hospital emergency department immediately if you notice any signs of bleeding . you should not take more than the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . keep this medicine in the original package in order to protect from light . if you notice any visible signs of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains - the active substance is clopidogrel . each 75 mg film - coated tablet contains 46 mg of the active substances ( listed in section 6 ). - the other ingredients are : tablet core : acetylsalicylic acid (asa ) 75 mg tablet : clopidiogrel ( hydrogen sulphate ) 75mg film - coating - tablet coat - coating : hypromellose ( e464 ), mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil
simbrinza contains the active substance brinzolamide . brimonidine tartrate is a substance that belongs to a group of medicines called carbonic anhydrase inhibitors , which work by blocking the action of the chemical in the body that allows brin zolamide to be absorbed by the body . this is called alpha - 2 adrenergic receptor agonists . it is used to reduce pressure within the eye . the other ingredient is brinza , which is used for the treatment of eyes in adults and adolescents aged 18 years and older with eye conditions such as glaucoma ( ocular hypertension ), high
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines taken to treat depression or parkinson ' s disease ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given simbr
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should only be used in the eyes . wash your eyes thoroughly with soap and water . do not use it after the expiry date which is stated on the carton and on the bottle after " exp ". this is to make sure that the medicine is clear and colourless to slightly opalescent . avoid touching your eyes with your hands ( see section 2 ). remove the cap , snap collar and the medicine from the bottle . gently squeeze your fingers through the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects while taking this medicine : - a reaction to the medicine ( frequency not known ). signs of an allergic reaction may include severe skin reactions such as rash , redness , itching all over your body , eyes trouble breathing , chest pain or irregular heart beat . contact your doctor or pharmacist immediately . - extreme tiredness or dizziness . other side effects that may occur while taking simbrinza with other medicines such as brinzolamide or brimonidine : common side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should if you accidentally use too much of this medicine , contact your doctor or pharmacist as soon as possible . the recommended storage times and conditions are the same as for all other medicines . however , if you forget to use
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 micrograms / ml ) and 5 milligrams / ml ( equivalent to 1 . 3 milligram / ml ). - the other ingredients are benzalkonium chloride ( see section 2 under " important information about the active substance ") in the package leaflet for further information on the use and stability of the suspension . - the following ingredients are present in the pre - filled syringe ( s ) of simbr
filgrastim ratiopharm is a type of medicine that contains the active substance filgrastam ( a protein called escherichia coli ). it is a natural protein produced by biotechnology in the body called granulocyte - colony stimulating factor ( gffr ), which stimulates the bone marrow to produce new blood cells . this results in more blood cells , called white cells . white cells are important as they help your body fight infection . filgrasterim ratisopharm helps to increase the number of white blood cells in your body . your doctor will tell you how many white cells you have . fil
you must not be given filgrastim ratiopharm : if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you must tell your doctor if you think you may be ( or might become ) allergic , hypersensitive or have a pulmonary disorder . the following side effects have been reported in patients with sickle cell disease 57 : left upper abdominal pain or pain at the tip of your shoulder ( a spleen disorder ). if you experience any of these side effects
always take filgrastim ratiopharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take . the usual starting dose is two tablets ( 0 . 5 mg per kilogram bodyweight ). your doctor may increase your dose to one tablet ( 1 mg ) twice a day for up to 30 days . the duration of your treatment varies from 14 days to 14 days depending on the severity of some disease types . the maximum recommended dose for patients with advanced stage of filgr
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you experience left upper abdominal pain ( pain at the tip of your shoulder ) if you suffer from a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests before and during treatment to check for the presence of neutrophils ( a type of white blood cells ) in your blood . during treatment , your doctor may adjust your dose or stop treatment . other medicines tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . tell your
keep out of the sight and reach of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the vial label after exp . this medicinal product does not require any special storage conditions . store in the original package in order to protect from light . after first opening , the product should be used immediately . however , if the product is cloudy or contains particles , it should be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment
what filgrastim ratiopharm contains the active substance is filgrasterim . each ml of solution for infusion contains 60 milligrams of filgrateim . filgrasteim ratisopharm 30 mg : each pre - filled syringe contains 0 . 5 milligram ( i . e . 30 mg / ml ). the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 and water for injections . the ingredient scorbitol is contained in the vial . see end of section 2 . for further information on the use of fil
raluzole zentiva contains the active substance riluzole which belongs to a group of substances called cytokines . cytokines are involved in the nervous system and play an important role in learning and understanding things that are not there ( see section 2 under ' important information about cytokines and their activity '). what roluzole ventiva is used for the treatment of amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells in the muscles contract , leading to weakness , muscle waste and paralysis . this results in the destruction of nerve cells . some people with motor neur
you must not be given riluzole zentiva : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you suffer from any liver disease . if you have increased blood levels of some enzymes of the liver called transaminases . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor if you think you may have any liver problems . yellowing of your skin or the whites of your eyes ( jaundice ). itching , feeling sick or being sick . problems with your kidneys . fever . a low number of white blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the tablets should be taken by mouth at about the same time each day . the recommended dose is 12 mg once a day . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or the nearest hospital emergency department immediately . if possible , take the tablets with a glass of water . do not take a double dose to make up for a forgotten tablet . if any of the above apply to you , talk to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience fever ( increase in temperature ). during treatment with riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will do a blood sample to check these numbers . this will help you to decide if you are more likely to get infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , microcrystalline cellulose ( e460i ) tablet coating : ahydrous colloidal silica , magnesium stearate . tablet coat : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). printing ink : shellac , white to off - white , round , oval , with " gsi " on one side and " 50 " on the other side . r
emgality contains the active substance galcanezumab . it is a medicine that blocks the action of a protein called calcitonin gene , which is involved in migraine . increased levels of cgrp in the blood can lead to migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines have been associated with an increase in the frequency of migraine headache and improve your quality of life .
do not take emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can be life - threatening . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . signs and symptoms of serious cardiac diseases tell your doctor as soon as possible if you notice any side effects described in section 4 . possible side effects in children and adolescents emg
always use emgality exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 240 mg / m2 body surface area ( subcutaneous injection ). your doctor will work out the right dose for you based on your condition . if you have any further questions on the use of this medicine , ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality include rash and itching . serious allergic reactions ( rare : may affect up to 1 in 1 , 000 people ) include difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions such as red skin , itching , bruising
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 8 hours at room temperature ( up to 7 ). if used within 30 days , do not throw away any medicines via
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 micrograms of galcanesumab in 1 ml solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 ( e433 ), sodium chloride and water for injections . what emgonality looks like and contents of the pack emginality is a solution for injection in a clear glass syringe . the solution is clear to slightly yellow . the syringe is a single - dose pen . pack sizes of 1 , 2 or
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hep ) in which blood vessels in the liver become damaged , leading to blood clots . it belongs to a group of medicines that have been given prior to a stem cell transplantation . the doctor or nurse who is given this medicine is experienced in the treatment of this condition .
do not take defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : are taking other medicines to prevent blood clots ( tissue plasminogen activator warnings ) medicine to prevent bleeding if you experience heavy bleeding after a blood transfusion or surgery if you have problems with blood circulation or a constant blood pressure ( see section 1 ). you may need to take other medicines for blood clotting ( such as acetylsalicylic acid , hepar
the treatment with defitelio will be started by a doctor experienced in the treatment of stem cells transplantation . it will be given by infusion into one of your veins as an ' intravenous infusion ' ( drip ). the duration of this treatment is 21 days . if you have any further questions on the use of this medicine , ask your doctor or nurse .
like all medicines , defitelio can cause side effects , although not everybody gets them . if you get any of the side effects listed below , talk to your doctor or pharmacist immediately . very common ( may affect more than 1 in 10 people ): low blood pressure ( common ) may affect up to 1 out of 10 people : bleeding in general bleeding ( the nose bleeding ), the brain bleeding , the gut vomiting , blood bleeding from the lungs bleeding , blood in the urine , the mouth bleeding , and the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon ( may
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . this medicinal product does not require any special storage conditions . the infusion storage will be stored in a refrigerator ( 2 - 8 ). do not freeze . if you notice that the solution is cloudy or contains particles , ask your pharmacist how to throw away the medicine you no longer use .
what defitelio contains - the active substance is defibrotide . each ml solution contains 2 . 5 mg / ml of solution for injection ( ph - adjustment ). - the other ingredients are : solvent : sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 for further information on solvent handling . - the solvent for solution for infusion contains 10 ml ( 0 . 5 %) of concentrate .
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver . it is caused by the hepatitis c virus . this medicine works by reducing the amount of virus in your body , which can cause hepatitis c to multiply . by blocking the virus from spreading to other parts of the body , it reduces the chance of the virus getting into your blood . your doctor will tell you how long you should continue to take this medicine . taking other medicines to treat hepatitis c infection tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . your
do not take daklinza : if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). if you take it by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum perfor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than that if you notice an unpleasant taste . your doctor may tell you to take some other medicines . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is given in combination with sofosbuvir or ribavirin , the following side effects may occur : very common ( may affect more than 1 in 10 people ): headache fatigue common : common : difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles if you have been treated with either of the two active substances in combination , you may be more likely to get these side effects . common : headache nausea feeling sick fatigue reduction in red blood cells ( anaemia
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg , 60 mg or more ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ) ( see section 51 for further information on the use of dak
proquad is a vaccine that protects against measles , mumps , rubella , chickenpox ( varicella ) viruses . the vaccine contains antibodies against the diseases that cause mumps and rubella . the antibodies help to prevent diseases caused by these viruses . proquad is used in adults , adolescents and children aged 9 years and older . it is given to you by a doctor or nurse .
do not use proquad : - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using proquad if : - you have a blood disorder ( a type of cancer that affects the immune system ). treatment with medications that weaken your immune system ( e . g . low - dose corticosteroid therapy for asthma ) or replacement therapy for a weakened immune system . - you suffer from a disease ( including aids ) with congenital or hereditary
proquad is given by injection into a muscle ( under the skin ) in the thigh or upper arm . injections are given into the muscle ( thigh area ) at the injection site . if you have a blood clotting disorder with low levels of platelets , the vaccine may not be suitable for you . the vaccine should not be injected into the skin to prevent bleeding from the muscle . proquad should only be given to patients with a blood vessel . the recommended dose of proquad is 9 mg per injection . children and adolescents from 9 years of age and older there is no experience of chickenpox or measles in this age group .
like all vaccines , including medicines obtained without a prescription , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : very common ( may affect more than 1 in 100 people ): seizures ( a fever ) rare ( likely to affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other possible side effects of proquad are : common : may affect up
what proquad contains the active substances are : measles virus1 , edmonston strain 3 . 00 mg : mumps virus1 ( level b ) strain 4 . 30 mg : rubella virus2 . the other ingredients are : type 3 : varicella virus3 , merck strain , 3 . 99 mg : tissue culture : plaque - forming units 1 , chickembryo cells , fibroblasts ( mrc ), powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate
jylamvo is injected into the body as an anticancer medicine to prevent unwanted reactions . it is an immunosuppressive agent . it acts as an anti - inflammatory effect . it can be used to treat rheumatic and skin diseases such as active rheumatoid arthritis , polyarthritic forms in the joints , and severe juvenile idiopathic arthritis ( jia ). it is used in children and adolescents ( 3 years of age and older ) who are not taking non - steroidal inflammatory drugs ( nsaids ) because of inadequate o severe or disabling psoriasis . treatment with phototherapy ( ps
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe kidney impairment or a liver impairment . if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia ). 34 a weakened immune system may lead to a serious infection such as tuberculosis or hiv . ulcers in the stomach or intestines may be a sign of an inflammation of the mucous membrane of the mouth . mouth ulcers have been reported
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jylamvo is one tablet once a day . if you have severe side effects that may lead to even death , your doctor may change the dose of the treatment . rheumatoid arthritis and severe juvenile idiopathic arthritis . severe psoriasis . if severe psoriatic arthritis has not responded to the treatment you may need a long - term treatment . your doctor will tell you how much and how often to use the medicine . for rheumatic and skin diseases
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds , nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry stools
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label and carton after exp . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately . accidental spillage may occur up to 3 hours after preparation . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each vial of solution contains 2 mg / ml ( 0 . 5 %) of the recommended dose of methotroxybenzoate . - the other ingredients are : tablet core : macrogol 400 micrograms glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e218 ), sodium methyl parahydroxybenzybe ( e219 ), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroben
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . this medicine is used to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to tighten , making breathing difficult . using this medicine relieves the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . if you have any further questions on the use of this medicine , ask your doctor or pharmacist
do not take enurev breezhaler : if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if this applies to you , stop taking this medicine and contact your doctor immediately if you experience tightness of the chest , coughing , wheezing or breathlessness . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist immediately . warnings and precautions talk
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhaler once a day . this medicine should be used for 24 hours at room temperature ( up to 75 ). if you use more enurev breezhaler than you should if you have accidentally used too much of this medicine , contact your doctor straight away . if you forget to use an inhaler and capsules ( in blisters ), use the medicine as soon as you remember . the capsules should be swallowed whole with a glass of water . do
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : very common ( may affect more than 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms include excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing dizziness allergic reaction swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 23 . 5 microlitres ). - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . - the mouthpiece of the inhaler contains a white to off - white powder , which is supplied in a device called an inhaler . capsules are supplied in blisters . each blister strip contains 6 or 10 hard capsules . the following pack sizes are available : multipacks containing 90 ( 3 packs of 30x1 ) hard capsules
the active substance of riximyo is called a " monoclonal antibody ". it attaches to a specific type of white blood cell . when rituximab sticks to the target of the antibody , it stimulates the immune system to produce more cells . this results in an increase in the number of cells that the body can produce . the treatment is given to you by a doctor or nurse who is experienced in the treatment of a ) non - hodgkin ' s lymphoma . this is a disease of the lymph tissue that affects a certain type of immune system called the b - lymphocytes . rix
do not use riximyo - if you are allergic to rituximab , other proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have a severe active infection at the moment , have a weak immune system , have severe heart failure , or have severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyagiitis or pemphigus vulgaris ). if any of these apply to you , tell your doctor or pharmacist before you are given r
always use riximyo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this treatment will be given to you by a doctor or nurse who is experienced in the use of this medicine . if you have any side effects , talk to your doctor , pharmacist or nurse before you are given the dose . your doctor will decide if you need to change the dose and duration of your treatment . the dose will depend on the type of medicine you are being treated with . the recommended dose is one tablet once a day . this will be divided into two equal doses . rix
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions may occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what riximyo contains - the active substance is rituximab . each vial contains 10 mg of 100 mg ritukimab in 10 ml solution . each ml contains 50 mg , 500 mg or 1000 mg ( 3 mg / ml ). - the other ingredients are : tablet core : sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 for further information on sodium ). - solvent : clear , colourless to slightly yellowish solution for infusion . pack sizes of 2 , 3 , 1 or 2 vials . not all pack
the active substance topotecan actsavis is a type of medicine that contains the active substance thrombocytopecan . it is used to treat the following conditions : - small cell lung cancer that has not been treated with chemotherapy - advanced cervical cancer that is not treated with surgery or radiotherapy - patients with advanced renal cancer in which treatment with medicines called cisplatin is not suitable .
do not take topotecan actavis : - if you are allergic to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will check your blood cell counts regularly to make sure that they are not too low . if any of these apply to you , tell your doctor straight away . if you have any kidney problems , your doctor may need to adjust your dose or stop the treatment . if your doctor thinks you may be at risk of severe kidney impairment or liver problems , inform your doctor . if this applies to
always use topotecan actavis exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is based on the severity of the disease and the results of blood tests . treatment in adults small cell lung cancer : 1 . 5 mg per kilogram of body surface area ( m2 ) for the first 5 days of this treatment cycle . in cervical cancer : 0 . 75 mg / m2 of bodysurface area , for the second 3 days after the first dose . if you have cervical cancer , your doctor may prescribe another anticancer medicines called cisplatin .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects very common ( may affect more than 1 in 10 people ) fever . this may be a sign of your general condition . local symptoms include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may affect your ability to fight infections . lung inflammation may occur ( rare , may affect up to 1 in 1 , 000 people ) difficulty in breathing , cough and fever . these may be signs of this severe condition called interstitial lung disease
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . store in the original package in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at a concentration of 25 micrograms / ml ( 2 to 8 microlitres ). the drug product solution should be used immediately after dilution in solutions for infusion ( nacl 0 . 9 mg / ml ). the concentration of glucose in solution for infusion is 5 microgram
what topotecan actavis contains - the active substance is topofecan . each vial contains 1 mg / 4 ml of topotecaan ( as hydrochloride ). after reconstitution , each 1 ml vial of 1 ml solution contains 2 mg / 1 . the other ingredients are : - tablet core : mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see end of section 2 for further information on the use of this product in children and adolescents ). - coating : aluminium seals with plastic flip - off caps and a protective sleeve . pack
what rivastigmine hexal is and what it is used for - the active substance is rosigmine . rosagmine belongs to a group of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia associated with parkinson ' s disease , certain nerve cells die in the brain . this happens when the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ) is released into the bloodstream . by blocking the enzymes that break down this substance , rosogmine helps to increase the levels of an important substance called acetyl
you must not be given rivastigmine hexal : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have had a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you experience irregular or slow heartbeat , an active stomach ulcer , difficulties in passing urine , seizures , asthma , severe respiratory disease , impaired kidney function , impaired liver function , trembling , a low body weight , gastrointestinal reactions such as feeling sick ( nausea ), being sick ( vomiting ), diarrhoea , being
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment the recommended dose of rivastigmine hexal is one tablet once a day . your doctor may prescribe a low dose depending on how you respond to treatment . the highest dose is 6 . 0 mg per kilogram of body weight . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take your doctor will tell you how many tablets to take . it is important that you continue to take riv
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking rivastigmine hexal and tell your doctor straight away if you notice any of the side effects listed below : very common ( may affect more than 1 in 10 people ) dizzy loss of appetite stomach problems such as feeling sick ( nausea ) being sick ( vomiting ) diarrhoea common : may affect up to 1 in every 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon : may affects up to one in 100 people depression
keep out of the sight and reach of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light .
what rivastigmine hexal contains - the active substance is 64 mg . - the other ingredients ( excipients ) are : capsule content : capsule contents : capsule shell : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin ( e460 ), yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac ( e553b ). each rivasta hexal 1 . 5 mg film - coated tablet is engraved with the code " r1 . 5 " on one side and " 3 " on the other
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) and liver cancer in combination with a specific anticancer medicine called sorafenib . cabometyx works by blocking the action of a protein called receptor tyrosine kinases ( rtyks ), which are involved in the formation of new blood vessels . by blocking these proteins , it increases the activity of high amounts in cancer cells . if you have any questions about why this medicine has been prescribed for you , ask your doctor .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabometrix : if you have high blood pressure or have had an aneurysm ( enlargement or weakening of a blood vessel wall ). if you develop a tear or a tear in or around the vessel wall . if you experience diarrhoea . if any of these apply to you ( or you are not sure ), tell your doctor . if recent events have resulted in significant bleeding ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one tablet once a day . your treatment should be started at the same time each day . if you take more cabometyx than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . do not stop your treatment unless your doctor tells you to . serious side effects may occur after stopping treatment . your doctor will tell you how many tablets to take . the usual starting dose is one 60 mg tablet of cabomet
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines used to treat your side effects : tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea or feeling sick ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain in
what cabometyx contains - the active substances are cabozantinib ( s ) and malate . each tablet contains either 20 mg or 40 mg cabozatinib . - each tablet is available in blister packs containing 20 tablets of cabozentinib , and in multipacks containing 40 tablets . - the other ingredients ( excipients ) are cabostyx 40 mg / m2 tablet ( s ), malate and water for injections ( see end of section 2 for more information ). - the tablet core contains microcrystalline cellulose , lactose anhydrous , hydroxypropyl cellulose
pemetrexed hospira is a medicine used to treat a type of cancer called " advanced stage " that has spread to other parts of the body . it is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in patients with advanced stage ( advanced stage ) of cancer whose disease has spread beyond the original line of treatment , initial chemotherapy is usually given to you . if you are being treated for advanced stage of lung cancer , pemet
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to pemrexed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not possible during treatment . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children less than 6 months of age because it is not recommended to breast - feed during the first few weeks of treatment . if you have been vaccinated against a vaccine against yellow fever , your doctor may decide to stop your treatment with pemet
always use pemetrexed hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 500 micrograms per kilogram of your body ' s surface area . your height and weight will depend on how well your body is responding to treatment . this body surface area will be calculated by your doctor depending on your response to treatment and on your blood cell counts . your doctor may also adjust the dose if necessary . if necessary , you may be given a lower dose ( 0 . 9 ml / kg ) of sodium chloride solution . the administration of pemet
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever or signs of infection , such as a temperature or sweating . infection may affect more white blood cells than normal . infection ( sepsis ) may lead to death . chest pain with a fast heart rate , pain , redness , swelling or sores in your mouth . signs of allergic reaction such as skin rash , burning or prickling sensation or fever . skin reactions may be life - threatening and could result in death . a severe rash , itching or blistering ( ste
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . infusion solution : the product should be used immediately . infusion solutions of pemetrexed should be stored at room temperature ( up to 25 ) for 24 hours prior to use . the reconstituted solution should be administered immediately after preparation . parenteral medicines : if there is discolouration prior to administration , this medicine should be discarded . any unused solution
what pemetrexed hospira contains - the active substance is pemrexed . one vial ( 100 mg ). each vial contains 100 mg of petrexed ( as pexyrexed disodium hemipentahydrate ). - the other ingredients ( excipients ) are water for injections ( see section 2 ) and powder for concentrate for solution for infusion ( see also section 4 ) and solvent for solvent for inhalation . - the recommended dose for use in children and adolescents is 500 mg ( 1 , 000 mg ) per vial . if you have the impression that the effect of pemet
ganfort contains two active substances called bimatoprost and timolol . both help to control pressure in the eye . bimatraoprost belongs to a group of medicines called prostamides . it acts on a prostaglandin analogue ( a substance in the body that transports blood from the body to the eye ) and helps to block the action of medicines known as beta - blockers . ganfort is a clear , watery liquid that is injected into the eye by your eye . it is used to treat glaucoma in adults , adolescents and children aged one year and above . it works
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . if you experience wheeziness , difficulty in breathing or long - standing cough . warnings and precautions talk to your doctor or pharmacist before using this medicine . coronary heart disease ( symptoms such as chest pain , tightness , breathlessness or choking ). heart failure ( symptoms include low blood pressure 44 ). disturbances of heart
always use ganfort exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eye once a day . treatment should be started as soon as possible . keep the bottle tightly closed in order to protect from light . do not put the bottle near your neck or eye . 1 . wash your hands with soap and water . 2 . remove the bottle from the eyelid and put it in a small pocket . 3 . put your eye back in the corner of your eye after treatment . 4 . open the lid of the
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and talk to your doctor straight away if you notice any of the following side effects after using the capsules : common side effects ( may affect up to 1 in 10 people ) - the eye redness . uncommon side effects in children and adolescents ( from 1 to 9 years of age ) - sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the eye ( inflammation ), difficulty in seeing clearly , redness , itching of the eyelids , hair
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . if you have any further questions on the use of this product , ask your doctor or pharmacist .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ). - the other ingredients are timolol ( 5 mg per kg of body weight ) ( see end of section 6 . 8 ), benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid , sodium hydroxide . what gansfort looks like and contents of the pack the clear , colourless to slightly yellow solution for the eye is supplied in a plastic bottle . each pack
gefitinib mylan contains the active substance gefitinib . this protein is involved in the growth and spread of cancer cells and is very similar to a natural protein found in the body . gefitoninib melan is used to treat non - small cell lung cancer in adults . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have ever had or might now have any other lung problems . some lung problems may be life - threatening . if any of these apply to you , tell your doctor straight away . - have or have had problems with your liver . your doctor will tell you how long you should continue to take the medicine . - are under 18 years old . other medicines and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 250 mg antacids taken once a day on your stomach ( see section 2 , " how to take gefitinib mylan "). if you have trouble swallowing the tablets , you can take them with or without food . if you take more tablets than you should if you accidentally take too many tablets , or if someone else accidentally takes your tablets , talk to a doctor or go to the nearest hospital straight away . do not take more than the
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness or sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs known as ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib mylan can cause severe skin reactions that affect the entire body . the signs
what gefitinib mylan contains - each film - coated tablet contains 250 mg of the active substance in one tablet . - the other ingredients are : - tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidaone ( k30 ), sodium laurilsulfate , magnesium stearate . - film coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . - printing ink : see end of this leaflet for further information . what g
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ), which cannot be treated with red bloodcell transfusions . your doctor or nurse will give you rifampicin ( a type of medicine called erythropoietin therapies ) to treat beta - thalassaemia ( a blood problem that is passed down through genes ). signs and
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to have a pregnancy , ask your doctor or pharmacist for advice before taking this medicine . if you have thalassaemia ( a condition where the spleen is removed from the body ) or have had a blood clot . your doctor may recommend hormone replacement therapy to prevent a previous blood clot from forming . preventive measures should be taken by your doctor , pharmacist or nurse before taking medicines to reduce the risk of a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will do blood tests before and during treatment with reblozyl . the recommended dose is one injection under the skin . the injections should be given at least 1 . 0 ml of water per kg of body weight . the dose may be adjusted depending on your blood pressure . in patients with myelodysplastic syndromes , the maximum single dose ( 1 . 75 ml ) is sufficient to control your body weight ( beta - thalassaemia ). if you use more re
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects include difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , blurred vision , symptoms of a stroke , blood clots swelling in the area around the eyes , lips , mouth or tongue throat allergic reactions 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to a maximum of 25 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours at 2 to 8 . any unused medicinal product or waste material should be
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg . - the other ingredients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( to adjust ph adjustment ). see section 2 for further information on ph adjustment . what rebloxyl looks like and contents of the pack rebl ozyl is a white to off - white powder for solution for injection in a vial . each vial contains either 25 mg , 75 mg or 100 mg of lusp
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor . it works by inhibiting the growth and spread of the cancer . it stops the growth of cancer cells by blocking their growth and spreading to new blood vessels . in patients with advanced kidney cancer , other treatments ( alpha or interleukin - 2 ) have been shown to slow down or stop the progression of your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used to treat depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotifda . if you have high blood pressure , your doctor will check your blood pressure regularly . your doctor may need to adjust your dose of a medicine to treat this condition . if any of these apply to you ( or you are not sure ),
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days . for 7 days , take 1 capsule of capsules of 4 mg twice a day . your doctor will tell you how many capsules to take . if you have any further questions on the use of this medicine , ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a common side effect ( may affect up to 2 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may need to adjust your dose of fotivda to control your blood pressure . if you take more fotvda than you should if you accidentally take too many tablets of a medicine , contact your doctor straight away . if
what fotivda contains the active substance is tivozanib . each vial contains 890 milligrams of the other ingredients ( listed in section 6 ). the other ingredient ( s ) are : capsule contents : tablet core : tivosanib hydrochloride monohydrate ( e460i ). tablet coating : 890 micrograms of tivuzanib , mannitol , magnesium stearate . capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e464 ) and strong ammonia
stribild contains the active substance elvitegravir . it is an antiretroviral medicine known as an integrase inhibitor cobicistat . it acts as a booster ( pharmacokinetic enhancer ) for the body to produce its own immune system ( immune system ) ( the body ' s natural defence system ) and helps it fight its own virus ( the hiv ) infection . stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ). it is used to treat hiv infection in adults , adolescents and children aged 12 to 18 years
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you start treatment . you should not take any medicine containing tenfuzosin without first checking with your doctor . your doctor may need to adjust your dose or change your dose depending on your kidney function . some of these medicines may be more effective than alf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults 12 to less than 18 years of age the recommended dose is 35 mg taken by mouth once a day . take your medicine at the same time each day . your doctor may adjust the dose of your medicine depending on how you respond to the treatment . you may also take medicines called oral supplements ( such as antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) for up to 4 weeks . if you take more stribild than you should if you
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in some cases to the restored health of the body . restored health is restored after treatment with stribild . as with all medicines , this medicine can cause side effects , although not everybody gets them . hiv infection can be caused by unwanted effects on the hiv disease itself . serious side effects tell your doctor or pharmacist immediately if you notice any of the following side effects : lactic acidosis , which can occur when you take too many hiv medicines
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each film - coated tablet contains 150 milligrams ( mg / m2 ). each tablet contains 300 milligram ( mg ). - the other ingredients ( excipients ) are : capsule - shaped tablets : e464 ( e464 ) ( e460 ) ( tablet core : ten ofovir desoproxill 300 mg )( tablet coating : e463 ( e470b ) ( film - coating : 10ofov
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics . it is used to treat schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes ( symptoms of excitement or euphoria ) have been reported in patients treated with zypoxa and have a recurrence of these symptoms in patients with bipolar disorder ( manic episode ). if you have any further questions on the use
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include a rash , itching , a swollen face , swollen lips and shortness of breath . if you have eye problems such as glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these conditions : if you think you may have a problem with your eyes , tell your doctor straight away . if this applies to you , talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa tablets is one 5 mg tablet twice a day . your doctor may increase your dose to one 20 mg tablet once a day depending on your symptoms . swallow the tablet whole with a glass of water . do not crush or chew the tablet . how long to take take your tablets at the same time each day . swallow your tablets whole with some water . you can take the tablets with or without food . if you take more tablets than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face and tongue . this may be a sign of blood clots in the veins . this side effect may occur more often in patients with 100 or more legs . symptoms include swelling , pain and redness in the leg which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you experience any of these symptoms , contact your doctor immediately . fever , faster breathing , sweating , muscle stiffness and drowsiness or sleep
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . zyprexa must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
zyprexa contains the active substance olanzapine . each zyprexa tablet contains 2 . 5 mg / 5 mg , 7 . 5mg / 10 mg or 15 mg / 20 mg film - coated tablets . the other ingredients are : tablet core : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), carnauba wax . see section 2 under " important information about the different ozprexa tablets strengths " for more information . zy
what prolia is prolia contains denosumab , which is a protein ( monoclonal antibody ). this is another protein that plays an important role in preventing bone loss in patients with osteoporosis . how prolia works prolia helps to make bone stronger by reducing the amount of a substance called oestrogen in the blood . this helps to prevent bones from becoming thin and fragile . it is also used in adult patients whose bones have not fully formed after the menopause . when treatment with prolia makes bone stronger , it makes it easier for the bones to break , thus reducing the risk of oste
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolia . prolia may cause a skin infection . symptoms include a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ). symptoms include fever . these symptoms may be due to an allergy to latex . remove the needle from the pre - filled syringe and use a derivative of latex
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe ( 60 ml ) once a day for up to 6 weeks . your doctor will give you a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . if you have any further questions on the use of prolia , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can cause skin infections such as cellulitis . if you experience any of these symptoms , stop taking prolia and contact your doctor straight away : swollen , red area of skin in the leg that feels hot and tender . symptoms may include fever . some of the symptoms of prolia may include pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness or feeling of heaviness or loosening of a tooth . these could be signs that there may be bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after the injection , the product may be stored at room temperature ( up to 25 ) for up to a maximum period of up to 30 days . if you have any further questions on the use of this medicine , ask your pharmacist .
what prolia contains the active substance is denosumab . each vial contains 1 ml of solution for injection ( equivalent to 60 mg / ml ). the other ingredients are : acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear , colourless to slightly yellow solution . it is supplied in a pre - filled syringe with a needle guard .
always use ambirix exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one vaccine for adults , adolescents and children from 1 month to 15 years of age . if you have two diseases : hepatitis a and hepatitis b infection . the hepatitis a virus causes the liver to become swollen and inflamed by the virus . the virus causes faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains , feel very tired , dark urine , pale
do not use ambirix : - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using the vaccine : if you have an allergic reaction such as itchy skin rash , shortness of breath or swelling of your face or tongue . if you think you may have an allergy reaction to any vaccine containing hepatitis a or hepatitis b diseases , tell your doctor straight away . a severe infection with a high temperature should not be a reason to give the vaccine . a minor infection , such as a cold , should not
always use ambirix exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one injection per day . the injection will be given into a muscle ( usually in the upper arm ) by a doctor or nurse . your doctor will tell you how many injections you need . the injections will usually be given by injection into a vein ( usually into the thigh muscle ). a total of two injections may be given . if the injections are given within 12 months of the first injection , the second injection should be given between 6 and 12 months after the
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , or a sudden drop in blood pressure or loss of consciousness . other side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired , irritable pain or redness
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units ( hepatitis b surface antigen ). the other ingredients are human diploid ( mrc ) cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate , 0 . 4 ml , sodium chloride , and water for injections . what Ambirix looks like and contents of the pack suspension for injection is a white , slightly milky liquid , supplied in a glass vial . each pack contains 1 or 10 pre
besero is a meningococcal group b vaccine . bexsero contains the active substance , the bacteria neisseria meningitidis group b . bexsero is used in adults , adolescents and children 2 years of age and older to prevent disease caused by a member of the class of bacteria called the nasopharyngitis group b bacteria . these bacteria cause infections such as meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by preventing the disease from returning to normal .
do not use bexsero : - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before being vaccinated . if you have a severe infection with a high temperature . before vaccination , you should tell your doctor if you had a minor infection such as a cold . vaccination is not recommended in patients with haemophilia or any other problem that prevents your blood from clotting properly . blood thinners ( anticoagulants ) are not recommended during treatment with eculizumab . if any of these apply to
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg injection into a muscle ( usually in the thigh or upper arm ). injections should be given every 2 to 5 weeks . your doctor will give you three injections to make up for three missed doses . the vaccine may be given as an additional injection ( booster ). the first injection should not be given more than 2 weeks after the missed dose . the interval between injections should not exceed 1 month . if you have any further questions on the use of this product , ask your
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the injected site , hardness at the area of injection site . the following side effects have been reported with this vaccine : common : may affect up to 1 in every 10 people : fever , loss of appetite , tenderness on the injectionsite ,
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each vial contains 1 , 2 , 3 or 50 micrograms ( 23 microlitres ). - the other ingredients ( excipients ) are group b fungal protein ( e . g . group b noada protein ) which is contained in the vial in 1 ml solution and in 2 ml solution in 3 ml solution for injection in outer membrane vesicles ( omv ). - nisseria manningitidis type a group b fhbp fusion protein is contained
what nitisinone mdk is and what it is used for this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children aged 1 year and above . because of this disease your body does not produce enough of the amino acid tyrosine ( amino acids ) that it needs to make its own medicine . this means that it does not work as well as it should if it has been given to you by a doctor who is experienced in the treatment of hty . this medicine works by helping your body make better use of the acids it produces . nitis
do not take nitisinone mdk : - if you are allergic to any of the active substances of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy and breast - feeding if you have been told by your doctor that you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor if this applies to you . driving and using machines do not drive or use machines if you feel that your eyes are not working properly . your doctor may recommend an eye examination . if you experience eye problems due to inadequate diet
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact a doctor or go to the nearest hospital straight away .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , nitisinone mdk should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not be longer than 2 hours at a temperature not above
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains one or two active substances . - the other ingredients are : tablet core : nitisisinone . see section 2 for more information on the active substances , see section 4 for further information . tablet coating : see section 5 for information about how to prepare and swallow the capsules . - each capsule contains either one or more active substances ( e . g . fentanyl ) or one 5 mg tablet . each tablet contains one active substance ( i . e . fentanyl ). the other ingredient ( s ) is gelatin , titanium dioxide (
docetaxel accord will be given to you by a doctor or nurse under the supervision of a doctor experienced in the treatment of cancer with anti - cancer medicines called taxoids . the name of the medicine in this leaflet refers to a type of breast cancer called non - small cell lung cancer . it is used in combination with prostate cancer , gastric cancer and head and neck cancer . if you have advanced breast cancer , your doctor may prescribe docetaxelo together with doxorubicin , trastuzumab or capecitabine . in early breast cancer with lymph node involvement , the doctor may
do not take docetaxel accord : - if you are allergic ( hypersensitive ) to the active substance or any of its other ingredients ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse if you have a history of low numbers of white blood cells or a severe liver disease . your doctor will tell you what precautions you need to take to protect you and your family . before you are given docel accord , your doctor may do blood tests to check that you have enough blood cells and that your liver is working properly . if any of these apply to you , tell your doctor immediately .
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . method and route of administration docetaxell accord is given as an infusion into one of your veins . the infusion will last approximately one hour . your infusion will be repeated every 3 weeks . your doctor will check your blood tests to make sure that you have the general condition to be treated . if you have any further questions on the use of this medicine , ask your doctor , nurse or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . during your treatment with docetaxel accord , the number of red blood cells and white blood cells ( alopecia ) may increase , leading to nausea , vomiting , sores in the mouth , diarrhoea and tiredness . if you experience any of the following adverse events while being treated with this medicine , tell your doctor or pharmacist immediately : - allergic reactions ( may affect up to 1 in 10 people ) flushing skin reactions such as itching chest tightness difficulty in breathing fever chills back pain low blood pressure more severe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after dilution , the medicine should be used immediately . the infusion bag may be stored at room temperature ( up to 6 ) for up to 25 days . after infusion , the infusion solution should be stored in non - pvc bags for 48 hours ( 2 to 8 ). if not used immediately ,
what docetaxel accord concentrate for solution for infusion contains : one vial of 20 micrograms ( 1 ml ) of concentrate contains 20 milligrams ( 1 . 5 mg ). the other ingredients in the concentrate are : 1 ml ( 0 . 5 ml ) concentrate contains 80 milligram ( 1 mg ) of docelaxel . each 8 ml ( 2 . 5 %) concentrate contains 160 milligams ( 1 , 4 %) of docilaxel ( 2 mg ) and 4 ml ( 10 %) ethanol anhydrous ( see section 2 for further information ). the solvent is citric acid
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . intuniv is used to treat impulsive ( hyperactive ) behaviours in adults , adolescents and children aged 12 years and above . this medication is used in adults to treat ' attention deficit hyperactivity disorder ' ( adhd ). it is used when current stimulant medication is not suitable or when current medication has not helped to control adhd symptoms . the medicine is used as a treatment programme for psychological therapy , educational therapy and social therapy in adults aged 38 years and older with adhd
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have low or high blood pressure , heart problems , or heart problems . tell your doctor if you fainted or have recently had thoughts or feelings of suicide or any other psychiatric conditions . withdrawal symptoms such as increased heart rate may be more likely to occur . if you know that your heart is not working properly , talk to a doctor or nurse straight away . if any of these apply to you
your treatment will be supervised by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of intuniv is one tablet once a day . your doctor will work out the right dose for you based on your condition . the usual starting dose for your treatment is 1 tablet per day . this will be gradually increased over the course of 1 to 3 weeks . depending on how you respond to treatment , your doctor may increase your dose from 0 . 05 mg to 0 . 12
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and contact your doctor immediately . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect associated with high blood pressure . symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur during treatment , stop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister pack and the carton after exp . this medicine does not require any special storage conditions . keep this medicine in the original package in order to protect from light . the tablets should be used immediately . blister pack : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains - the active substance is guanfacine hydrochloride . each long - term prolonged - release tablet contains 1 milligram ( mpa ). each extended - release film - coated tablet contains 2 milligrams ( mma ). - the other ingredients ( excipients ) are : - the first 3 mg long - lasting tablets are : ( see end of section 2 for further instructions on how to prepare and use the tablet ) - the second 3 mg extended - lasting tablet is : - each extended , extended - duration tablet contains 3 million mpa . - the third 24 - week extended -
ecalta contains the active substance anidulafungin . ecalta is used in adults and adolescents ( aged 1 to 18 years ) to treat fungal infection in the blood or other internal organs caused by invasive candidiasis . the infection is caused by the growth of fungal cells called candida ( echinocandins ). these medicines are used to treat serious fungal infections caused by fungal cell walls that have not been properly closed or where the immune system ( the body ' s natural defence system ) has not been able to break down the cells and make them resistant to their own immune system . ec
do not take ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may need to monitor your liver function . if you have liver problems , your treatment may be interrupted or you may be given anaesthetics during or after your treatment . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist . warnings and
always take ecalta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 200 mg twice a day . this may be increased to 100 mg once a day for up to 1 month . adults , adolescents and children aged 18 years and above the recommended dose is 3 . 0 mg per day . your doctor may increase the dose to 200 mg two times a day or to 1 . 5 mg per kg of body weight depending on the patient ' s weight . if you have any further questions on the use of this medicine , ask your doctor , pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - threatening allergic reactions , such as difficulty breathing or wheezing . these may be signs of an existing rash . ecalta can cause serious sideeffects such as convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheeing or coughing , difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hyp
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the reconstituted solution should be used within 24 hours after preparation . the infusion solution may be stored at room temperature ( up to 25 ) for up to 48 hours . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2 to 8 .
what ecalta contains - the active substance is anidulafungin . each ml of powder contains 100 micrograms of aldefangin . - the other ingredients are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and water for injections . each carton contains 30 single - use syringes of the powder .
adynovi contains the active substance rurioctocog alfa pegol , which belongs to a group of substances called pegylated human coagulation factor viii ( hfvviii ). the humancoagulationfactor viii is produced by recombinant dna technology in the blood . it helps to form clots and stop bleedings in patients with haemophilia a and b . adynovi is used for the treatment of bleeding in adults and adolescents 12 years of age and older . in this group of patients , it is used in combination with other medicines for the prevention of haem
do not use adynovi if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , talk to your doctor or pharmacist . warnings and precautions tell your doctor , pharmacist or nurse if you : - have ever had an anaphylactic reaction ( a severe , sudden allergic reaction to any substance in the body ), or if you have ever been in close contact with someone who has allergic reactions ( e . g . rash 95 , hives , wheals ), general
always use adynovi exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have haemophilia , your doctor will tell you how many tablets to use . the duration of treatment will depend on the type of bleeding you are suffering from . your doctor may decide to stop the replacement therapy if you do not respond as well as you should . if your doctor thinks that you may be unsuitable , he or she may recommend that you stop using adsynovi for a life - long treatment . always use this medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience sudden allergic reactions ( anaphylactic ) following the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if you have severe symptoms such as difficulty in breath , fainting , prompt emergency treatment . previous treatment with factor viii ( 150 mg or more of treatment ) inhibitor antibodies (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the powder vial after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial tightly closed in order to protect from light . after reconstitution , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at room temperature ( up to 3 ). once reconstituted , this medicine should be used within
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains either 250 , 500 , 1000 or 2000 iu of the corresponding active substance in the solution . - the other ingredients are : - the solvent vial containing 5 ml of sterilised water , water for injections , mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydroxymethyl ) aminometh
rekovelle contains the active substance follitropin delta , which is a follicle stimulating hormone . it belongs to a group of hormones called gonadotropins and is used to stimulate female fertility . it is used in women undergoing assisted reproduction programmes ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ( intrf ). it stimulates the ovaries to produce many eggacs .
do not use this medicine if any of the following apply to you : - you have or have had your fertility problems . - you are allergic to follicle stimulating hormone . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents rekovelle should not be used in children below 6 years of age . - the tumour in your uterus ( ovaries ), breasts , pituitary gland or hypothalamus ( enlarged ovaries ). - cysts on your ovaries ( polycystic ovarian disease ). - bleeding from the vagina ( an early menopause ). - malform
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of the rekovelle dose for your first treatment cycle is anti - müllerian hormone produced by your ovaries . stimulation with gonadotropins in your blood will depend on your body weight . your doctor will ask you to take a blood sample during the last 12 months to check how well your body is responding to treatment . the dose may be adjusted by your doctor depending on the amount of hormone in your body and on the results of your blood sample taken over the last
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones can lead to infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , stop taking rekovelle and contact your doctor straight away . a side effect that may affect up to 1 in 10 people is headache . nausea is a common side effect in women ( ovulation syndrome ) and ovarian hyper
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , rekovelle may be stored at room temperature ( up to 8 ) for a single period of up to 25 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 3 hours at room
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 milligrams ( 0 . 36 millilitre of solution ). each ml of solution contains 33 . 3 micrograms ( 1 . 5 millilitres ). - the other ingredients ( excipients ) in the solution are : tablet core : phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for injections . what recovelle looks
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each inhalation contains either one of the following active substances : ellipta 92 micrograms ( 0 . 5 milligrams ) per inhalation , each containing one inhalation . each dose contains two doses , each corresponding to 22 microgramms . each of the two active substances is either one or both of the other active substances . - in patients with chronic obstructive pulmonary disease ( copd ), asthma is a common ( occurring in less than 12 months of age ). the usual dose is 184 micro
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking ellipta . ellipta should not be used if you have liver disease . the following side effects have been reported with ellipta in patients with moderate or severe liver disease : the lower strength of ellipta 92 / 22 mg may be associated with heart problems , high blood pressure , tuberculosis ( tb ) of the lung or any long standing or untreated infections
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . asthma the recommended dose for asthma is fluticasone furoate ( equivalent to 22 mg vilanterol ) once a day . if you have severe asthma , your doctor may prescribe the higher strength inhaler ( e . g . one inhalation per day ) that delivers the most effective dose of fluticasaone fiburoate 22 mg per day . vilterol is used to treat copd . in adult patients with copd , the usual dose is two inhalations per day
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak , light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipta your breathing may become
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each inhalation contains 92 micrograms ( 0 . 92 milligrams ). - the other ingredients ( excipients ) of the inhalation are : - the solvent for the inhaler is a clear , colourless to pale yellow solution for injection in a glass vial called a dose counter . it is supplied in a foil laminate tray with a peelable foil lid and a desiccant sachet . each pack contains 69 inhalers . - the packaging contains the device and the foil lam
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , which is also known as a nucleosidermal growth factor receptor agonist ( nrti ) and tenofovir , which are all active substances in the treatment of hiv . these active substances belong to a group of antiretroviral medicines that work by blocking an enzyme ( reverse transcriptionase ) that causes the virus to multiply . at
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . swallow the tablet whole with a glass of water . atripla can be taken with or without food . take the tablet on your stomach at least 1 hour before or 2 hours after food . some side effects may be more common ( dizziness or drowsiness ). if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . if you forget to
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in some cases to the restored health of the body . if this happens to you , you may need to stop taking atripla . as with all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). serious side effect tell your doctor immediately if you notice any of the following serious side
what atripla contains - the active substances are efavirenz and emtricitabine . each tablet contains tenofovir disoproxil ( as fumarate ). - the other ingredients are : tablet core : croscarmellose sodium , hyprolose , magnesium stearate . tablet coating : microcrystalline cellulose , sodium laurilsulfate ( see end of section 2 for more information on the active substance ). what the tablet film coating contains : iron oxide black , iron oxide red , macrogol 3350 , poly ( vinyl alcohol ), talc
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . this is the natural gonadonrophin releasing hormone ( gnrh ). gnrh regulates the release of gonadsotrophins ( a type of follicle stimulating hormone ) in the body . gonadosrophins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells so that the follicles can be grown and fertilised . orgalut
do not use orgalutran if : you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). you are hypersensitive to gonadotrophin releasing hormone ( gnrh ). you have agnrh analogue . you suffer from a moderate or severe kidney or liver disease . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the product if you : have an active allergic condition . your doctor may need
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will be given to you by a doctor or nurse who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of each cycle . the recommended dose is one injection per day . you should inject the first injection under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will tell you how long you should
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect very common ( may affect more than 1 in 10 people ) is local skin reactions ( redness and swelling ). the local reaction usually disappears within 4 to 10 minutes . uncommon : may affect up to 1 in 100 people . headache , nausea and malaise may occur within 1 to 10 , 000 people . allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing ( angioedema , anaphylaxis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the syringe label after exp . this medicinal product does not require any special storage conditions . syringes should be clear , solvent - free solutions .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( see section 2 ). - the ph contains sodium hydroxide ( e433 ) and acetic acids ( e464 ) which are present in the vial and in the solution after subcutaneous administration . see section 4 for further information on the use , handling and disposal of the product in this pack . what orgalautran looks like and contents of the pack orgaluitran is
what blitzima is blitzima contains the active substance rituximab , which is a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocytes ". when ritukimab sticks to this target , it stops the growth of these cells . how blitzima works blitzima can be used in adults to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ). this means that a certain number of a - lymphocyte - forming cells , called " white blood cells " ( b -
do not use blitzima : - if you are allergic to rituximab or other proteins that are made by recombinant dna technology or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if you : - have a severe active infection , have a weak immune system , have severe heart failure , or have severe uncontrolled heart disease . - have granulomatosis ( polyangiitis ). - are at risk of microscopic polyangiaitis ( pemphigus vulgaris ). you should not be given
always take this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this treatment is one tablet once a day . if you take more blitzima than you should if you accidentally take too many tablets , contact your doctor immediately . you may need to take other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma , the usual dose of blitzima alone blitzima is given every 4 weeks . however , if you forget to take blitzima if you miss a dose
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions may occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains - the active substance is rituximab . each vial contains 10 mg of 100 mg . - the other ingredients ( excipients ) are : powder for solution for infusion : 10 mg , 50 mg , 500 mg ritukimab in 10 ml . - solvent : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for concentrate for infusion . each pack contains 2 vials , 50 ml or 1 vial . not all pack
roactemra contains the active substance tocilizumab , which is a type of monoclonal antibody , which attaches to a protein called interleukin - 6 ( iu ) in your body . it works by blocking the inflammation caused by your body in the form of micrograms ( mg ) of ticl - 6 , which can cause symptoms such as pain and swelling in your joints . by attaching to mg it prevents the damage to the cartilage that lines the bone in the joints . this reduces the risk of the disease developing and relieves the pain . roactem
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . if this applies to you , stop the infusion and contact your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the infusion . if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash during the infusion , tell your doctor or pharmacist immediately . infections if you feel unwell ,
always use roactemra exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the intravenous infusion will be given to you by a doctor or nurse . the duration of the treatment will depend on your body weight . the recommended dose for adults and children aged 8 years and older is 4 mg / kg once a day . for children aged 4 to 8 years , your doctor will give you a drip in the vein ( intravenous infusion ). the usual starting dose is 2 mg per kg of body weight , but your doctor may increase your dose to
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported ( frequency cannot be estimated from the available data ): very common side effects ( may affect more than 1 in 10 people ): allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever , chills , mouth or skin blisters . stomach ache signs and symptoms of liver toxicity ( may occur in up to 1 in 1000 people ): tiredness , abdominal pain , j
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and the vial label after exp . this medicine does not require any special storage conditions .
what roactemra contains - the active substance is tocilizumab . each vial contains 4 mg of 80 mg of tociluzumab ( corresponding to 20 mg / ml ). each 10 ml ampoule contains 200 mg of the other ingredients ( listed in section 6 ). - the other ingredient ( s ) are : tablet core : sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactoremra looks like and contents of the pack roactamra is a concentrate for solution for infusion
onbrez breezhaler contains the active substance indacaterol , which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the walls of the small air passages in the lungs . this helps to ease breathing difficulties associated with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to relax , making breathing difficult . this medicine helps to relax these muscles , making it easier for air to get in and out of your lungs .
do not take onbrez breezhaler if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . before you are given this medicine , tell your doctor if you : - have heart problems - have epilepsy - have thyroid gland problems ( thyrotoxicosis ) - have diabetes . your doctor will decide how long you should be treated with this medicine and will tell you if you need to stop treatment . - have tightness of the chest , coughing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 micrograms once a day depending on how you respond to the treatment . use your inhaler every 24 hours . how to use onbrez breezhaler your doctor will give you an inhaler and capsules ( in blisters ) to help you inhale the medicine . the inhalation powder is clear and colourless . do not chew or crush the capsules . if you use more on
what onbrez breezhaler contains - the active substance is indacaterol . - the other ingredients ( excipients ) in the powder for the capsules are lactose and the capsule ( s ) contains gelatin . one capsule of the 300 micrograms solution for inhalation contains 300 microlitres ( i . e . indiacaterol maleate ). - the ingredients in the capsule also include lactose , the capsule , and gelatin . - each onbrex breez inhaler 300 micrometres ( e . g . printing ink ): printing ink: printing ink : printing ink that contains indac
clopidogrel hcs is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping and preventing the formation of blood clots ( a process known as thrombosis ) it reduces the risk of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), which can lead to a rare but potentially life - threatening condition called atherothrombotic events ( such as stroke , heart attack , or death ). clopidsogrel clcs is
you must not be given clopidogrel hcs : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if any of these apply to you , tell your doctor or nurse straight away . you may need to take special precautions while you are being given the product . you should not have to be given the same dose of clop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of clopidogrel hcs per day . if you experience severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg ) of the medicine . your doctor will tell you how long you should continue to take it . the usual starting dose for people with this condition is two 75 mg tablets once a day . however ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what clopidogrel hcs contains - each film - coated tablet contains 75 mg of the active substance in one tablet . - the other ingredients ( excipients ) are : - tablet core : hydrochloride ( see section 2 for further information ). - tablet coating : cellulose ( e460 ), microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil ( e470b ). - film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics ( e . g . cephalosporins ) if you have had a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking fetcro
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will give you an infusion ( a drip ) into a vein ( intravenously ) over a period of 3 to 2 hours . the duration of fetcroja treatment will depend on the type of infection you have and on the severity of your infection . if you experience any pain during the fetcroja infusion , it will be given to you by a doctor or nurse . it is recommended that you inject the medicine directly into your vein . kidney problems if you have kidney problems , your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction , which may include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may be accompanied by diarrhoea , stools , blood or mucus . treatment with medicines to slow bowel movement is not recommended . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg ccfiderocol . - the other ingredients are sucrose , sodium chloride , sodium hydroxide and water for injections . what fetcoja looks like and contents of the pack fetcroja is a white to off - white powder for solution for infusion . each pack contains 10 vials . not all pack sizes may be marketed .
depocyte is used to treat the following conditions : lymphomatous meningitis ( a condition in which tumour cells accumulate in the membranes of the brain and spinal cord ). depocyte is a type of medicine that works by blocking the growth and spread of lymphoma tumours .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using depocyte if you have a meningeal infection . severe neurological side effects with depocyte may occur . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop using any dexamethasone tablets and contact your doctor immediately . unwanted effects your side effects will be checked by your doctor .
always use depocyte exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . depocyte is given by injection into the lumber sac . the recommended dose of depocyte for injections is 1 to 5 mg dexamethasone ( 5 mg ). each depocyte dose will be given to you by a doctor experienced in the treatment of any side effects associated with depocyte . your doctor will determine the correct dose based on your body surface area ( temperature ) 22 to 30 . before withdrawing depocyte from the vial , take proper precautions to avoid exposure to a cytotoxic drug .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported during your treatment with depocyte : very common side effects ( may affect more than 1 in 10 people ): common : common in 1 to 10 people : uncommon in 100 people : common : may affect up to 1 in 1 , 000 people : not known frequency cannot be estimated from the available data reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . depocyte must be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . once depocyte has been removed from the refrigerator , it must be used within 4 hours . if depocyte is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at room temperature ( up to 30 ). do not throw away any medicines via
what depocyte contains - the active substance is cytarabine . each ml of solution contains suspension equivalent to 10 mg cytarbine ( equivalent to 5 mg / ml ). each vial of 50 ml contains 50 mg ( 23 mg ) of the other ingredients of depocyte ( listed in section 6 ). - the other ingredient is cholesterol , triolein , dioleoylphosphatidylcholine ( type a ), dipalmitoyl phosphATidylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is supplied as
what bemrist breezhaler is the active substance is indacaterol . it belongs to a group of medicines called bronchodilators . it works by tightening the muscles in the lungs . this helps to open the airways and allows air to get in and out of the lungs more easily . mometasone furoate is also a member of a medicine called corticosteroids . it is used in combination with steroids to reduce the swelling and irritation ( inflammation ) in the small airways in which you breathe . this can cause breathing problems and can lead to attacks of asthma . what bem
do not take bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , low level of potassium in your blood , severe liver problems , tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . if any of these apply to you , tell your doctor immediately .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with some water . swallow the capsules whole with a glass of water . do not chew or crush the capsules . the medicine should be used immediately . if your asthma does not improve or your symptoms get worse , your doctor may prescribe a lower dose . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction ( uncommon ) may affect up to 1 in 100 people : swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other possible side effects tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . store in a refrigerator ( 2 - 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler contains 125 mg , 62 . 5 mg or 173 mg of the active substance in one inhaler . - the other ingredients are indaconaterol acetate ( 150 mg ) and imocaterol 80 mg ( 100 mg ). - the two active substances in the inhaler are both excipients ( e . g . mometa furoates ). the mouthpiece of the inhaled inhaler is supplied with 125 mg or 127 . 5
the active substance of zyllt is clopidogrel , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping and preventing the formation of new blood clots ( thrombosis ), zylt reduces the risk of developing blood blots ( also known as thrombi ) forming in hardened blood vessels ( arteries ), which can lead to atherothrombotic events ( such as stroke , heart attack , or death ). your doctor or nurse will give you zyll
do not take zyllt : if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking zllt . you should tell your doctor if you : - have a history of bleeding ( e . g ., aomach ulcer ) or a blood disorder that causes internal bleeding or bleeding inside any tissues , organs or joints of your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of zyllt per day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg ) to be taken once a day . swallow the tablet whole with a glass of water . do not crush or chew the tablet . you can take the tablet with or without food . take it at the same time
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 milligrams of clopidiogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil . tablet coating : hypromellose , titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyll
lamivudine teva is an antiviral medicine that works by reducing the amount of the hepatitis b virus in your body . it is used to treat long term ( chronic ) hepatitis b infection in adults and adolescents aged 18 years and older . lamivudINE teva belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . it can also infect other parts of the body . this is linked to the way your body works , and can result in liver damage and compensated liver disease . your doctor will monitor your liver function during
do not take lamivudine teva - if you are allergic to lamibudine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine 28 if you think any of these apply to you , ask your doctor or pharmacist for advice before taking it . do not swallow the tablet with water or other similar medicines . serious side effects if you have liver disease such as hepatitis c . you may be overweight . your doctor will do blood tests before you start your medication . see section 4 for further information . if you take
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . the duration of your infection depends on your illness . your doctor will tell you how long you should take it . if you have any further questions on the use of this medicine , ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva : other conditions linked to hepatitis b . tell your doctor straight away if you notice any of the following serious side effects during or after therapy with ' hepatitis b ': the most common side effects reported during the first few weeks of the treatment of hepatitis b in clinical trials were tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting and diarrhoea . increases in liver enzymes ( enzymes that help to relax muscles ). allergic reaction (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . lamivudine teva must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamivuine . - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ). tablet coating : white to off - white , oblong , biconvex film - coat : 32 . what lamiv
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not produce enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by blocking the effect of the natural hormone erythropoietin in your blood , which helps your bone marrow produce more of the white blood cells called darbepoetin alfa . chronic renal failure ( symptomatic anaemia ) is the term used to refer to a condition that occurs when you have kidney failure . if kidney failure occurs , your doctor may remove the natural
do not take nespo : if you have high blood pressure or are taking other medicines . if you are allergic to darbepoetin alfa or r - huepo . warnings and precautions talk to your doctor , pharmacist or nurse before taking any of the following medicines to treat sickle cell anaemia : epileptic fits ( seizures ). convulsions ( fits ). liver disease . drugs to treat anaemia may cause an allergy to latex . the needle in the pre - filled syringe is a derivative of latex . symptoms include unusual tiredness and lack of energy . pure red cell aplasia
your doctor will do blood tests before and during treatment with nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight . your doctor may increase your dose to ahaoglobin level that is between 10 and 12 microgram . the pre - filled syringe should be injected directly into a vein ( intravenous ). if you have chronic renal failure , your doctor will give you a single injection under the skin ( in a vein ) to reduce the risk of your anaemia . the recommended dose for patients with a history of renal failure is a dose of 0 . 75
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) - high blood pressure ( hypertension ) - fluid retention ( oedema ) uncommon : may affect up to 1 in 100 people - formation of blood clots ( thrombosis ) - pain in the area injected rash , redness on the skin rare : these may occur in 1 to 10 , 000 people - serious allergic reactions - sudden life - threatening allergic reactions ( anaphylaxis ) - swelling of the face , lips ,
keep out of the sight and reach of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 30 ) for a single period of up to 7 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . medicines should not be disposed of via wastewater or household
what nespo contains the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 mg , 15 mg , 20 mg , 30 mg , 40 mg , 50 mg , 60 mg , 80 mg , 100 mg , 130 mg , 150 mg , 300 mg or 500 mg . the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic and sodium chloride , polysorbate 80 and water for injections . the solution is clear , colourless to slightly pearly liquid and cloudy . 1 ml of solution for injection contains 4 pre -
macugen is a solution for the eye that contains the active substance pegaptanib . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for the treatment of macular degeneration in adults . this disease causes vision loss due to damage to a part of the retina called the macula ( the outer layer of the eye ). macula is the layer that connects the eye with the rest of the body . macula helps to protect the eye by preventing abnormal blood vessels grow in the retina ( the part that surrounds the retina ). macugen works by blocking the effect of the medicine . by blocking
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macugen if you think you may have an infection or bleeding in the eye . before macugen injection , tell your doctor immediately if you experience the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . the injection may cause the injection serious allergic reactions .
always use macugen exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much macugen to use the recommended dose of macugen is a single injection into your eye every 6 to 9 weeks . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen must be used in combination with antibiotic eye drops . if you use more macugen than you should if you inject more than one injection into the eye , contact your doctor immediately . you may need to use some local anaesthetic (umbing medicine ) to relieve any
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . the symptoms are listed in section 2 . if you experience any of these symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the outer carton in order to protect from light .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegptanib ( equivalent to 90 mg ). - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is a clear , colourless to pale yellow solution in a pouch .
kipivance contains the active substance palifermin , which belongs to a group of substances called escherichia coli . palifermine works by blocking the growth of epithelial cells in the mouth and digestive tract , which are tissues that line the skin . palififermin is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth ). this is the most common side effect that occurs during treatment with treatments for your blood cancer . if you have any of the following : - if you are having chemotherapy , radiotherapy or autologous hemopoietic stem cell transplantation
do not take kepivance : - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents below 18 years of age . other medicines and kepingivance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . this includes heparin . if you think you may be pregnant or are planning to have a baby , ask your
kpivance will be given to you by a doctor or nurse experienced in cancer treatment . your doctor will decide the dose you should receive . the recommended dose is one 60 microgram ( 0 . 5 millilitres ) injection . the dose that you will receive will depend on your condition and the type of cancer treatment you are being treated with . the usual dose given is one kilogram ( 1 millilitre ) injection into a vein . if you have any further questions on the use of this product , ask your doctor , nurse or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness , pruritus ( erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever , aching joints ( arthralgia ), altered taste , lipase levels ( amylase levels ) and digestive enzymes in the blood . treatment with kepivance may
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see end of this leaflet for further information on the use and handling of this product ). - the ingredients are : powder for concentrate for solution for injection in a vial . solvent for solvent for injection is a white powder . each pack contains 6 vials . not all pack sizes may be marketed .
cinacalcet accordpharma contains the active ingredient tacrolimus , which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck that help the thyroid gland to work properly . cinacal cordpharma is used in adults to treat secondary hyperparathyroidism ( secondary ) in patients with serious kidney disease who are on dialysis or who are receiving waste products that increase the amount of calcium in the bloodstream ( hypercalcaemia ), which can lead to parathy
you must not be given cinacalcet accordpharma : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . if your doctor determines that your blood calcium levels are too low . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , as there may be a risk of : - seizures ( fits or convulsions ). seizures may be life threatening events . - liver problems . - heart failure . your doctor will tell you if you need to be treated more frequently . if you take
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet a day . swallow the tablet whole with a glass of water . the tablets may be taken with or without food . your doctor will take regular blood samples before and during treatment to check if you have secondary hyperparathyroidism . the recommended starting dose for adults , adolescents and children aged 3 months to 18 years is 0 . 20 mg / kg body weight per day . if you take more cin
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - numbness or tingling around the mouth , muscle aches , cramps or seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). - swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea . vomiting . if you notice any of these side effects ( very common ), tell your doctor . uncommon ( may
what cinacalcet accordpharma contains - each film - coated tablet contains 30 mg , 60 mg , 90 mg or 100 mg ( as hydrochloride ). - the other ingredients are : tablet core : cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ) and iron oxide yellow ( e172 ). see section 2 for further information on the contents of the pack below . what the tablets look like and content of the tablet the 30 mg film -
jentadueto contains the active substance linagliptin and the other ingredients are metformin and biguanides , which belong to a group of medicines called dpp - 4 inhibitors . these are dipeptidyl peptidase - 4 inhibitor ( dp - 4 )- like substances that are produced naturally in the body and which help to control blood sugar levels . what is diabetes ? ' type 2 diabetes mellitus ' is a condition in which the body does not make enough insulin to control the level of sugar in the blood . this medicine is used in combination with certain other medicines used to treat diabetes
do not take jentadueto if : you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). you have severely reduced kidney function . you have uncontrolled diabetes . you suffer from severe hyperglycaemia ( high blood glucose ). you experience nausea , vomiting , diarrhoea and rapid weight loss . this condition is called lactic acidosis ( see section " warnings and precautions "). if any of these apply to you , or if you are not sure , talk to your doctor , pharmacist or nurse before taking this medicine . if you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is two individual tablets of linagliptin and metformin per day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . take the tablet with or without food . your doctor will tell you what dose of this medicine to take . if you have an upset stomach , your doctor may tell you to take a lower dose of 5 mg linaglaptin per day ( equivalent to 2 , 000 mg of metform
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may require immediate medical attention . stop taking jentadueto and contact a doctor straight away if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypocaemia is a very rare ( may affect up to 1 in 10 , 000 people ). the most common side effect that may be associated with the combination jentinueto plus sulphonylurea is the combined jent
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the original package in order to protect from light . keep this medicine in the outer carton to protect it from tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains two doses : one dose ( two tablets each 850 mg ) and two doses ( one tablet each 1 , 000 mg ) tablet . - the other ingredient ( s ) ( s) ( two units ) ( four tablets each 800 mg / 2 , 500 mg tablet ) contains two treatments ( two doses ) ( one and a half tablets each ). - the ingredients ( excipients ) are : tablet core : linag
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection in adults . edurant belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by stopping hiv from multiplying in the body . it is used in adults and adolescents 12 years of age and older who are infected with hiv and who have not been previously treated . it can also be used in children and adolescents aged 12 years to less than 18 years who are not fully immunised against hiv
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the following medicines : - carbamazepine , oxcarbazepine or phenobarbital - phenytoin - medicines used to treat epilepsy ( seizures ) - rifampicin or rifapentine - medicines to treat some bacterial infections ( tuberculosis ) - omeprazole , esomeprazole or lansoprazole - pant
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . children and adolescents edurant is for use in adults and adolescents ( aged 18 years and above ). your doctor will tell you how many tablets to take and how often to take them . your doctor may tell you to take one tablet of rifabutin at the same time each day . you should take it with or without food . it is important that you take the tablets with food . if you take more edur
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests , transaminase , increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body , triglycerides , lipase and bilirubin in blood uncommon ( may affect up
what edurant contains - the active substance is rilpivirine . each film - coated tablet core contains a sufficient amount of rilpaline hydrochloride ( equivalent to 25 mg / m2 ). - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose ( e460 ), magnesium stearate . the film - coating is composed of lactosemonohydrate , hypromellose 2910 , 6 mg , titanium dioxide ( e171 ), mac
avandamet tablets contain two different medicines called rosiglitazone and metformin . both of these two medicines help control the level of sugar in your blood . type 2 diabetes is a type of diabetes in which your body does not make enough insulin to control blood sugar levels . the insulin that your body makes does not work as well as it should , and it can cause problems with your body ' s ability to make the insulin it produces , such as low levels of sugar or too much sugar in the blood . your doctor has prescribed a sulphonylurea to treat diabetes .
always take avandamet exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . do not take more than one tablet in the morning or two tablets in the evening . if your diabetes is not controlled , talk to your doctor , pharmacist or nurse straight away . if you have had a heart attack , severe angina , heart failure or have had heart failure in the past , severe breathing difficulties , liver disease or diabetic ketoacidosis ( a complication of diabetes characterised by rapid weight loss , nausea and vomiting ). if
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose may be increased to 1 mg once a day for up to 8 days . the maximum dose should be reached at least 4 times a day . your doctor will tell you how many tablets to take . the recommended dose is one tablet a day , with or without food . if your doctor thinks that the effect is too strong or too weak , talk to
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions you should tell your doctor straight away if you experience raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you notice any of these symptoms you should contact your doctor immediately . the following side effect has been reported with metformin in patients with severe kidney disease . symptoms of lactic acidosis include rapid breathing , cold stomach pain , nausea and vomiting . these symptoms are usually mild to moderate and disappear within a few days .
keep out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and the vial label after exp . this medicinal product does not require any special storage conditions .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either one or two of the following active substances : - the other ingredients are : tablet core : 1 tablet of rosaiglitazeone and 500 mg metformine ( see section 2 ' avandamanet contains lactose ') - tablet coating : 2 tablets of rosciglitazaone and 1000 mg met formin . - tablet coat : 4 tablets of the active substance ( sildenafil )- the other ingredient is : sodium starch glycollate , hypromell
clopidogrel mylan is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumping and preventing the formation of blood clots ( a process known as thrombosis ) it helps to reduce the risk of a rare but potentially life - threatening condition called " clots " ( thrombi ) forming in hardened blood vessels ( arteries ), which can lead to atherothrombotic events ( such as stroke , heart attack , or death ). if you take clop
you must not be given clopidogrel mylan 31 - if you are allergic to any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist . before you have been given the medicine , you should discuss with your doctor the risks and benefits of taking cl
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of clopidogrel mylan per day . if you experience severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg / day ). if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding that appears under the skin as red pinpoint dots and / or confusion ( see section 2 " warnings and precautions "). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of theskin . these could be signs of an allergic
what clopidogrel mylan contains - each film - coated tablet contains 75 mg of the active substance in one tablet . - the other ingredients in the tablet core are : tablet core : hydrochloride , microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 for further information on the contents of the tablet ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide ( e172 ), talc ( e553b ) and mac
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults , adolescents and children ( 12 years of age and older ). it is used in adults with a condition known as thromboocytopenia ( a medical procedure that reduces the risk of bleeding ). it works by reducing the number of platelets in the blood . platelets are a type of blood cells that are important in helping the blood to clot and prevent bleeding .
do not use doptelet : if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). if you have ever had blood clots in your veins or arteries . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you are breast - feeding . you are undergoing hormone replacement therapy . you have recently had surgery or have been injured . 23 you are overweight . you suffer from advanced chronic liver disease . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and dopte
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for your procedure is one 5 mg tablet once a day for 8 days . if you take more doptelet than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . your doctor will tell you how many tablets to take and how often to take them . the usual starting dose for adults is one 20 mg tablet twice a day . this may be increased to a maximum of 40 mg once daily for up to 60 days . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired common : may affect up to 1 in 100 people : low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this
what doptelet contains - the active substance is avatrombopag maleate . each film - coated tablet contains 20 mg / ml of the active ingredient in this medicine . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . tablet coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). printing ink : the tablets are pale yellow , round
rapiscan belongs to a group of medicines called ' coronary vasodilators '. rapiscan is used to monitor the heart arteries ( heart rate ) and the muscles in the heart . it is given to you by a doctor or nurse who is experienced in the care of patients with a special type of heart condition called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken from the muscles of the heart using a readmill to measure blood flow . a scan may show that there is a small amount of radiationaceutical in the body . this
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease ( a pacemaker that causes chest pain ) or unstable angina ( a condition in which the heart does not pump enough blood to the body ). warnings and precautions talk to your doctor , pharmacist or nurse before starting treatment if you suffer from low blood pressure ( hypotension ) or heart failure . if you are allergic to regadenoson or any of the other ingredients in this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor or pharmacist before you start taking rapisc
rapiscan will be given to you by a doctor or nurse who is experienced in the use of rapiscan . the dose will depend on your heart rate and blood pressure . the recommended dose is 400 mg given as a 5 ml solution the injection may be given as 5 ml or 10 ml depending on your weight . your doctor may also give you an injection of sodium chloride 9 mg ( 0 . 9 % of your body weight ) or 5 ml of a radioactive substance ( radiopharmaceutical ). your doctor will tell you how many times you should be given the injection . the usual dose is one 5 ml vial
like all medicines , rapiscan can cause side effects , although not everybody gets them . some of the side effects may be serious and require immediate medical attention . if you notice any of the following , talk to your doctor , pharmacist or nurse straight away : - stop using the rapid heart beat low blood pressure fainting or mini strokes weakness of the face or inability to speak if you have recently been treated with a medicine that reduces the risk of having a stroke ( cerebrovascular accident ) - an allergic reaction ( such as rash , wheals / weals , swelling under the skin , around the eyes , throat
viagra contains the active substance sildenafil , which belongs to a group of medicines known as phosphodiesterase type 5 ( pde5 ) inhibitors . it works by stimulating the blood vessels in your penis to relax . this allows you to get an erection when sexually stimulated . viagra is used as a treatment for erectile dysfunction ( impotence ) in adult men who cannot get an erect penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which can cause a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). the medicines are also known as nitric oxide donors ( such as amyl nitrite ). if you have such a risk , you should stop taking these medicines and contact your doctor immediately . you have a risk that you may have an increased risk of having an increase in the level of angina
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg once a day . you can take viagra with or without food . viagra film - coated tablets are also known as viagra orodispersible tablets . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more viagra than you should if you accidentally take too many viagra tablets , contact your doctor straight away . if possible , take the tablet with some water . take it at the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking viagra and tell your doctor straight away if you notice any of the following side effects while you are being treated with viagra : - an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat , chest pains and a semi - sitting position . you may be given nitrates to relieve your chest pain . prolonged and sometimes painful erections may occur ( may
what viagra contains the active substance in viagra is sildenafil . each tablet contains 25 mg ( the citrate salt ). the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with " 25 " on one side
sifrol contains the active substance pramipexole . it belongs to a group of medicines called dopamine agonists . dopamine receptors in the brain are involved in transmitting signals to the brain . by blocking these signals , sifrol reduces the dopamine signals that cause nerve impulses in thebrain to relax and improve the symptoms of primary parkinson ' s disease . it is used in combination with levodopa to treat parkinson '. the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any medicine . if you have any medical conditions or symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are mild to moderate . dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may not be suitable for you . if any of these apply to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day for the first week . your doctor will tell you how many tablets to take . the usual starting dose is 1 tablet per day . swallow the tablet whole with a glass of water . the tablet can be divided into equal doses ( 0 . 088 mg or 0 . 264 mg ). if your symptoms do not improve after 1 week , your doctor may increase your dose to a maximum of 1 tablet each day . s
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects should be performed by a doctor experienced in the treatment of parkinson ' s disease . the following side effects have been reported with sifrol : very common ( may affect more than 1 in 10 people ): common : may affect up to 1 in 1 , 000 people : uncommon : may affects up to one in 10 , 000 patients : not known ( frequency cannot be estimated from the available data ): if you are not sure , talk to your doctor or pharmacist . other possible side effects : dyskinesia (
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg ( 0 . 18 mg ), 0 . 35 mg , 0 . 7 mg of the other ingredients ( listed in section 6 ). - the other ingredient ( excipients ) are : tablet core : povidone k 25 , magnesium stearate . tablet coating : mannitol ( e421 ), maize starch , anhydrous colloidal silica ( e553b ), povidoone k25 , magnesium starch . see section 4 for further information on the use of this product . what s
emadine is a medicine that is used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to treat allergic conditions that affect the surface of your eye . the allergic reaction to emadine may include allergic reactions to some materials ( allergens ). allergic reactions may include itching , redness , swelling and discolouration . if you notice any of these , you may feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride has not been studied in this age group . if any of these apply to you , tell your doctor . if you have any further questions on the use of this product , ask your doctor or pharmacist . your doctor may need to change the dose of emad
always use emadine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in the eye once a day . use this medicine at the same time each day . do not change the dose unless your doctor tells you to . your doctor will tell you how many drops to use and how often to use it . how long to use your eyes : the recommended starting dose is 1 dose in the morning and 2 doses in the evening . if you have more than 1 drop in your eye , use the em
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using emadine and talk to your doctor or pharmacist straight away if you notice any of the following side effects : common side effects ( may affect up to 1 in 10 people ) - eye pain - itchy eye - eye redness ( uncommon side effects ) - corneal disorder ( abnormal eye sensation in the back of the eye ) - increased tear production - tired eyes - eye irritation - blurred vision - cornea staining - dry eye ( general side effects include headache , difficulty sleeping , sinus headache , bad taste ,
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . keep the blister in the outer carton in order to protect from light . store in a refrigerator ( 2 - 8 ). do not freeze . keep it at room temperature ( up to 25 ) to prevent infections .
what emadine contains the active substance is emadastine . each ml contains 0 . 5 mg of difumarate , benzalkonium chloride , trometamol , sodium chloride . the other ingredients are hypromellose , purified water , hydrochloric acid , sodium hydroxide , acidity levels ( ph levels ) and water for injections ( see end of this leaflet for further information on the use of this product ). the solvent is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - liner ) bottle with a screw cap .
levetiracetam actavis is an antiepileptic medicine . it is a medicine used to treat seizures in epilepsy in adults , adolescents and children aged 16 years and older with newly diagnosed epilepsy . epilepsy is a type of epilepsy that involves repeated fits ( seizures ) occurring in different parts of the body . when levetiraacetam actsavis is used for the epilepsy , it is injected into the brain on both sides of the brain . partial onset seizure ( secondary generalisation ) has been reported in adults and adolescents aged 12 years and above with juvenile myoclonic epilepsy ( primary generalised tonic - clonic
do not take levetiracetam actavis : - if you are allergic to any of the active substances in this medicine ( pyrrolidone derivatives ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you have kidney problems or any slow down in the growth or puberty of your child , ask your doctor for advice . anti - epileptics should not be used in children and adolescents under the age of 18 years . if any of these apply to you , tell your doctor as soon as possible . do not give this medicine to children under 18 years of age . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose for adults and adolescents 16 years of age and older is 1 , 000 mg twice a day . your doctor may prescribe a higher or lower dose depending on how you respond to treatment . the usual starting dose for children and adolescents aged 2 years to less than 1 year of age is 2 tablets once a day , with or without food . therapy dose for adolescents 17 years of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed , dizzy or have difficulty breathing . these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms . a rash on the face with an extended rash . a high temperature . increased levels of liver enzymes seen in blood tests . a decrease in white blood cell 56 ( eosinophilia ). enlarged lymph
always take levetiracetam actavis exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet ( 250 mg ) once a day . your doctor will tell you how many tablets to take . the usual dose is two tablets ( 500 mg ). your doctor may tell you to take one tablet of 500 mg twice a day , depending on how you respond to the medicine . the dose that your doctor prescribes for you depends on your condition and on how long you tolerate it . the maximum recommended daily dose is : one tablet
what incruse ellipta is this medicine contains the active substance oumeclidinium bromide which belongs to a group of bronchodilators . it is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that affects the airways and makes breathing difficulties difficult . difficulties in breathing are due to tightening of the muscles in the lungs . this medicine helps to prevent tightening of these muscles in your lungs and relieves your breathing difficulties . if you have copd , ellipta can help to prevent a sudden attack of breathlessness and wheezing .
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have asthma . if you think you may have asthma , ask your doctor for advice . if any of these apply to you ( or you are not sure ), tell your doctor as soon as possible . if your doctor tells you that you have heart problems , or if you suffer from an eye problem called narrow - angle glaucoma ( an enlarged prostate ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one inhalation every 24 hours . you should use incruse ellipta every day at the same time each day . do not stop using this medicine without talking to your doctor first . if you have symptoms of this problem such as a sudden attack of breathlessness , wheezing or attack with a quick - acting reliever inhaler ( such as salbutamol ), you should continue to use the inhaler until your doctor tells you otherwise . how to use inc
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and contact your doctor immediately : itching skin rash , hives and redness 29 the following side effects have been reported with this medicine : common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead , inflammation of the sinuses ( sinusitis ), headache , constipation . uncommon side effects are likely to occur ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler and the sealed tray after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the opened tray in the outer carton in order to protect from light . once the seal has been removed from the refrigerator , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incruse ellipta contains the active substance is umeclidinium bromide . each inhalation contains 55 micrograms ( 1 . 5 millilitres ). the recommended dose for adults , adolescents and children aged 65 years and above is one inhalation powder . the other ingredients are : - tablet core : lactose monohydrate ( see end of section 2 for further information on lactose '), magnesium stearate ( e470b ). - solvent : solvent : water for injections ( e . g . a clear , colourless to light green mouthpiece cover ), a dose counter , a foil lam
nucala contains the active substance mepolizumab , which is a monoclonal antibody ( a type of protein that recognises and attaches to specific receptors in the body ). it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by many eosinophils ( an abnormal type of white blood cell that makes up the airways in the lungs ). how nucala works asthma in people with severe asthma attacks are usually treated with medicines called high dose inhalers to help control your asthma . these medicines can be taken with or without medicines called oral
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects . if you think your asthma is getting worse , ask your doctor or pharmacist for advice . your doctor may decide to reduce your dose or discontinue nucal treatment if you become allergic to injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions to parts of the body
nucala is given under the skin ( subcutaneous injection ). the recommended dose is 12 injections of 100 ml ( 1 ml ) per day . the pre - filled pen is for single use only . if you have any further questions on the use of nucala , ask your doctor , pharmacist or nurse . duration of treatment your doctor will tell you how long you should continue treatment . how long and how often to continue the treatment ? your doctor may decide to change your dose depending on your asthma symptoms and attacks . it is important that you continue to follow the instructions given to you by your doctor . if your asthma
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect up to 1 in 10 people ) after the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash . contact your doctor immediately if you experience a reaction similar reaction to those described above . if you have any further questions on
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . once removed from the refrigerator , the pen may be stored at room temperature ( up to 7 ) for a single period of no more than 7 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 7
what nucala contains - the active substance is mepolizumab . each vial contains 1 ml of solution for injection ( 100 mg ). - the other ingredients are : sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what the product looks like and contents of the pack nucal 1 mg is a clear , colourless solution . it is supplied in a pack containing 1 vial or a multipack containing 3 vials or 1 multipack . not all pack sizes
nolanaro is a cancer medicine that contains the active substance ixazomib . it is called a ' proteasome inhibitor '. ninlaro is used to treat a cancer of the bone marrow called multiple myeloma ( myel ). it is used for cell survival in adult patients . it works by blocking the action of a lot of proteins called proteasomes that are involved in the growth and spread of cancer cells . in adults , it is given to you by a doctor who is experienced in the development of this type of cancer . your doctor will test your body for these proteins before you start treatment with nin
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you ( or you are not sure ), tell your doctor straight away . if you have any further questions on the use of the product , ask your doctor or pharmacist . do not take any more tablets than the recommended dose . you may be more likely to have bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have multiple myeloma , your doctor will tell you how many capsules of this medicine to take . the recommended dose of ninlaro is lenalidomide , a medicine that contains dexamethasone . this is an anti - inflammatory medicine . your doctor may tell you to take more of it than you should if you take more than the prescribed dose . how much to take the recommended starting dose for adults is one capsule of one tablet of the same day of the week . the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting diarrhoea numbness or tingling or burning of the hands or feet peripheral neuropathy ) swelling of the legs or feet ( peripheral oedema ) skin rash or itchy areas of the body ( rare side effects may affect up to 1 in 1 , 000 people ): severe skin rashes , red to purple bumps ( sweet ' s syndrome ) rash
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . once the capsule has been removed from the refrigerator , it must be used immediately . keep this medicine in the original carton to avoid any damage to the product . medicine packaging should be clear and colourless .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg of ixezomib in 3 . 3 ml of solution . - the other ingredients are : capsule core : microcrystalline cellulose , magnesium stearate , talc . the capsule shell : gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ] ( see end of section 2 ). - printing ink : the capsule content is white to off - white , capsule - shaped ,
do not use palforzia : - if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before using palforbzia . children and adolescents from 4 to 17 years of age should not be given treatment for peanut allergy . peanut ( desensitisation ) is a substance present in the food and drink in the body that can cause allergic reactions . if you have any questions about food allergies or why this medicine has been prescribed for you , ask your doctor .
do not take palforzia : - if you are allergic to severe asthma or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma has a problem swallowing , or if you have long term problems with your digestive system ( e . g . a severe mast cell disorder , severe or life - threatening anaphylaxis ) which may occur within 60 days of starting treatment . warnings and precautions talk to your doctor , pharmacist or nurse before you start taking the medicine . your doctor may need to adjust your dose or stop treatment . if you think you may have been given more palf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have a history of allergy or allergic reactions ( anaphylaxis ). the recommended starting dose is 3 mg once a day . your doctor may increase your dose to a maximum of 20 mg once daily . the recommended duration of treatment with palforzia is initial doseescalation and up - dosing phases . these treatment phases may be repeated for up to 3 weeks depending on the severity of your asthma . the duration of initial dose escalation is 4 to 5 hours depending on how you respond
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions : if you experience any of the following symptoms while taking the medicine , tell your doctor straight away : - trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin pimply , problems with the stomach and digestive system ( eosinophilic oesophagitis )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . store below 25 . store in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine in the original package in order to protect from light . any hard lumps of powder should be disposed of in accordance with local requirements .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg or 20 mg . the other ingredients are : capsule contents : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg oral powder in capsules , with opening microCrystalline croulose ( e460i ), colloidal ahydrous siliconica ( e470i ) and magnesium unstearate . palfborzia 300 mg oralpowder in sachet capsule contents ( capsule contents ): - capsule shell : - capsule shells : capsule shell
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used for the treatment of sleeping problems . the duration of treatment is one month . if you have problems sleeping , talk to your doctor .
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zeren sleep apnoea syndrome ( short periods of time ) if you suffer from severe kidney or liver problems ( myasthenia gravis ). if you feel very weak , tired muscles , severe breathing or chest problems . children and adolescents do not give this medicine to
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . if you have difficulty falling asleep , do not take more than the prescribed dose . adults 65 years of age and older if you suffer from mild to moderate liver problems your doctor will tell you how many tablets to take . children and adolescents from the age of 65 years to less than 5 years your doctor may tell you to take one 5 mg tablet twice a day , depending on how you respond to the medicine . if the capsule is cloudy ,
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of the side effects listed below is defined using the following convention : 36 very common ( may affect more than 1 in 10 people ) common : may affect up to 1in 10 people 100 uncommon : may affects up to one in 10 , 000 people 1 , 000 rare : not known ( frequency cannot be estimated from the available data ) very rare : affects less than 1 user in 10, 000 people not known : frequency cannot been estimated from available data common :
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : tablet core : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate . tablet coating : lactose monohydrate , indigo carmine , titanium dioxide ( e171 ). printing ink : shellac , lecithin , simethicone ( e1520 ), yellow iron oxide ( e172 ) and water for injections ( see end of section 2 ). the printing ink is white to off - white , capsule - shaped , with
